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Description
[0001] The present invention relates to a process for the production of ∆5-unsaturated fatty acids in an organism by
introducing, into the organism, nucleic acids which encode polypeptides with ∆5-desaturase activity. These nucleic acid
sequences, if appropriate together with further nucleic acid sequences which encode polypeptides of the biosynthesis
of the fatty acid or lipid metabolism, can advantageously be expressed in the organism. The process can be used for
the production of non-methylene-interrupted fatty acids (NMIFAs) such as sciadonic acid (∆5cis-11,14-20:3) and juni-
peronic acid (∆5cis-11,14,17-20:4), which do not occur naturally in most food plants. The invention furthermore relates
to a process for the production of oils and/or triacylglycerides with an elevated content of long-chain polyunsaturated
fatty acids.
[0002] The invention furthermore relates to the nucleic acid sequences, gene constructs, vectors and organisms
comprising the nucleic acid sequences according to the invention, vectors comprising the nucleic acid sequences and/or
the gene constructs and to transgenic organisms comprising the abovementioned nucleic acid sequences, gene con-
structs and/or vectors.
[0003] A further part of the invention relates to oils, lipids and/or fatty acids produced by the process according to the
invention and to their use. Moreover, the invention relates to ∆5-unsaturated fatty acids and to triglycerides with an
elevated content of ∆5-unsaturated fatty acids and to their use.
[0004] Non-methylene-interrupted fatty acids (NMIFAs) have been found in algae, slime molds, marine sponges and
plants. Seed plants are botanically divided into gymnosperms and angiosperms. It is believed that the angiosperms have
evolved from their gymnospermous predecessors in the late Jurassic or early Cretacious. The seed oils of nearly all
gymnosperms contain ∆5-NMIFAs, usually in the form of C16-20 monoun-saturates (see, for example, Wolff et al, Lipids
1999, Oct; 34(10); 1083-1097). Similar ∆5-NMIFAs occur in the seed oils of a very few angiosperm species, predominantly
in the plant family Ranunculaceae but also found in some other "primitive" plant families, such as Menispermaceae and
Limnanthacea. In angiosperms, the unusual NMIFAs are invariably found only in the seed oils and do not occur in
vegetative tissue; this is in contrast to the gymnosperms, where the presence of these fatty acids in leaves is well-
documented.
[0005] Recent studies have shown biomedical benefits of ∆5cis-NMIFA-containing oils, such as triglyceride-lowering
effect and anti-inflammatory properties (Asset et al, 1999, Lipids, 34, 39-44; Berger et al, Lipids in Health and Disease
2002, 1:5, and references therein). Oils containing ∆5cis-11,14-20:3 sciadonic acid (SA) can also lower plasma cholesterol
in experimental animals. Several investigators have shown that the addition of sciadonic acid to animals or cultured cells
is effective in reducing the level of 20:4n-6 (arachidonic acid, ARA) in phosphatidylinositol (PI), thereby modifying cellular
ARA metabolism (Tanaka et al, 1999, Biochem. Biophys. Res. Comm., 264, 683-688; and Tanaka et al, 2001, Eur. J.
Biochem., 268, 4928-4939).
[0006] It would therefore be advantageous to be able to produce ∆5cis-NMIFAs such as sciadonic acid and juniperonic
acid in other organisms from where they can easily be extracted. One example of this is the production of the fatty acids
in the vegetative tissues of angiospermous plants.
[0007] It is known that polyunsaturated fatty acids such as arachidonic acid, eicosapentaenoic acid (EPA) and do-
cosahexaenoic acid (DHA) can be produced in a variety of ways. Thus, EPA or DHA are produced in marine bacteria
such as Vibrio sp. or Shewanella sp. via the polyketide pathway (Yu, R. et al. Lipids 35:1061-1064, 2000; Takeyama,
H. et al. Microbiology 143:2725-2731, 1997).
[0008] An alternative strategy is the alternating activity of desaturases and elongases (Zank, T.K. et al. Plant Journal
31:255-268, 2002; Sakuradani, E. et al. Gene 238:445-453, 1999). A modification of the above-described pathway by
∆6-desaturase, ∆6-elongase, ∆5-desaturase, ∆5-elongase and ∆4-desaturase is the Sprecher pathway (Sprecher 2000,
Biochim. Biophys. Acta 1486:219-231) in mammals. Instead of the ∆4-desaturation, a further elongation step is effected
here to give C24, followed by a further ∆6-desaturation and finally β-oxidation to give the C22 chain length. Thus what is
known as Sprecher pathway (see figure 1) is, however, not suitable for the production in plants and microorganisms
since the regulatory mechanisms are not known.
[0009] Our co-pending UK patent application No. 0523915.7 as well as UK patent application No. 0524420.7 teach
the production of polyunsaturated fatty acids in a variety of plants and microorganism by means of genetically modifiying
these species with a selection of nucleic acid sequences encoding a series of elongase and desaturase enzymes.
[0010] The present inventors have decided to adopt a similar strategy in order to produce ∆5-NMIFAs. In order to do
this, it was necessary to identify a desaturase capable of introducing a C=C double bond at the ∆5-position.
[0011] The biosynthesis of higher plant monounsaturated very long chain fatty acids (VLCFAs) containing a ∆5 double
bond was studied previously by radio labeling of developing Limnanthes alba seeds. The seed oil of Limnanthes spp is
enriched in the ∆5-eicosaenoic acid (20:1 ∆5). Based on in vitro analysis of of Limnanthes spp. seed extracts, Moreau
et al, Arch Biochem Biophys. 1981; 209:376-384 suggested that 20:0-CoA is the substrate for the ∆5-desaturase. In
more recent studies, random sequencing of EST library from L. douglasii seeds resulted in the identification of a candidate
cDNA for a ∆5-desaturase that showed similarity to known acyl-CoA desaturases from animals, yeast and cyanobactaria
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(Cahoon et al, 2000, Plant Physiology, 124, 243-251). Co-expression of this desaturase cDNA with an FAE1 (fatty acid
elongating activity) homolog from L. douglasii in soybean somatic embryos resulted in the accumulation of ∆5-monoun-
saturated 16:1, 18:1 and 20:1 fatty acids, thus confirming the pathway proposed for 20:1 ∆5 formation in Limnanthes spp:
a) a large flux of palmitic acid (16:0) from the plastid to the endoplasmic reticulum;
b) microsomal elongation of 16:0, presumably as a CoA ester, to eicosanoic acid (20:0),
c) ∆5-desaturation of 20:0 to form 20:1 ∆5 (see Cahoon et al, Plant Physiol. 2000 Sep;124(1):243-51 and references
therein).
[0012] However, no direct biochemical evidence has been presented to support the assertion that the Limnanthes
desaturases utilises acyl-CoA substrates, as opposed to the predominant glycerolipid or ACP-linked desaturation oc-
curring in plants.
[0013] Equally, cDNAs encoding proteins related to the animal and yeast acyl-CoA desaturases (abbreviated to ADS)
have been identified in several plant species, though their activity towards acyl-CoA substrates is inferred only from
homology (Fukuchi-Mizutani et al, 1998, Plant and Cell Physiology 39: 247-253).
[0014] Two cytoplasmic ADS enzymes from Arabidopsis , ADS1 and ADS2, formed ∆9-desaturated fatty acids when
expressed in yeast (Heilmann et al. 2004, PNAS, 101 (28), 10266-10271), Arabidopsis or in Brassica juncea (ADS1
only, Yao et al, 2003 Plant Biotechnol 1: 221-229). ADS3, another member of the Arabidopsis desaturase (ADS) multigene
family, was characterized as a gene, encoding palmitoyl-monogalactosyldiacylglycerol ∆7-desaturase. A conifera white
spruce (Picea glauca) homolog of ADS3 has been characterized as an 18:0 ∆9 desaturase gene by heterologous
expression in yeast (Marillia et al., 2002, FEBS Lett, 526: 49-52).
[0015] ∆5cis-C20 NMIFAs occur in seed and leaves in all Coniferae (see, for example, Destaillats et al, Lipids, 2001
Nov; 36(11); 1247-1254 and Wolff et al, Lipids. 2001 May; 36(5); 439-451). It was also found that seed oil of several
members of the rather primitive angiosperm family Ranunculaceae contains significant amounts of these unusual fatty
acids (see Wolff et al. 2002 for review: Lipids. 2002 Jan; 37(1):17-26 and see also Tsevegsuren et al, (1997) Hrc-Journal
of High Resolution Chromatography, 20: 237-241).
[0016] Cimicifuga spp., Caltha palustris L. and Anemone leveillei/rivularis are all reported to produce cis ∆5 desaturated
fatty acids, including 16:1 ∆5 and 18:1 ∆5 and (predominantly) 20:3∆5,11,14 (sciadonic acid). C. palustris produces
additional ∆5 desaturation products such as 18:4 ∆5,9,12,15 and 20:4,11,14,17 (juniperonic acid). In Caltha, Cimicifuga
and A. leveillei the main ∆5cis-C20 NMIFA is sciadonic acid (SA, 20:3, ∆5,11,14). It is found at levels of 19.7% of total
fatty acids in seed oils of C. palustris and of 9.8% of total fatty acids in Anemone seed oils. C. palustris produces additional
∆5 desaturation products such as 18:4∆5,9,12,15, 20:1∆5 and 20:4∆5,11,14,17 (Smith et al, 1968, Lipids 3: 37-&). We
have previously attempted to identify the ∆5-desaturase responsible for the synthesis of SA from Anemone, and initially
considered it likely that this enzyme was a cytochrome b5 fusion desaturase. Although Anemone contains several such
desaturases, none of them were identified as being involved in SA synthesis (Whitney et al. 2003, Planta, 217(6), 983-992)
[0017] The present inventors therefore hypothesized that the enzyme introducing a double bond at the ∆5 position to
yield SA might be an acyl-CoA desaturase similar to the group of membrane bound fatty acid desaturases recently
cloned from Arabidopsis, rose and Limnanthes and following this reasoning, have obtained nucleotide sequences which
encode a ∆5-desaturase enzyme. This has made possible the development of a process for the production of ∆5-
unsaturated NMIFAs in a variety of organisms.
[0018] Therefore, in a first aspect of the present invention, there is provided a process for the production of a compound
of formula (I):
in an organism, the process comprising introducing into an organism which comprises a lipid of general formula (III):
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at least one nucleic acid sequence comprising :
a) SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5;
b) a nucleic acid sequence which hybridizes under stringent conditions with a nucleic acid sequence of SEQ ID NO:
1, SEQ ID NO: 3 or SEQ ID NO: 5.
c) a nucleic acid sequence which encodes a polypeptide of SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6;
d) a derivative of a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 which encodes a
polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6,
wherein said polypeptide has ∆5-desaturase activity;
and expressing said nucleic acid sequence;
wherein, in general formulae I and III:
Y = a C10-C18 hydrocarbon chain containing up to four carbon-carbon double bonds;
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylg-
lycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol, sphingo base or a radical of
the formula II
in which
R2 = hydrogen, lysophosphatidyl choline, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysodiphos-
phatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturated C2-C24-alkylcar-
bonyl,
R3 = hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl, or R2 and R3 independently of one another are
a radical of the formula Ia:
in which
n = 2, 3, 4, 5, 6, 7 or 9, m = 2, 3, 4, 5 or 6 and p = 0 or 3;
and wherein an oxygen in the R1 radical may be replaced by sulphur such that
R1 is bonded to the remainder of the molecule via a thioester linkage.
[0019] In the context of the present invention "hybridizes under stringent conditions" is intended to describe hybridization
and washing conditions under which nucleotide sequences with at least 60% homology to one another usually remain
hybridized with one another. Conditions are preferably such that sequences with at least approximately 65%, preferably
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at least approximately 70% and especially preferably at least 75% or more homology to one another usually remain
hybridized to one another. These stringent conditions are known to the skilled worker and described, for example, in
Current Protocols in Molecular Biology, John Wiley & Sons, N. Y. (1989), 6.3.1-6.3.6. A preferred nonlimiting example
of stringent hybridization conditions is hybridizations in 6 x sodium chloride/sodium citrate (= SSC) at approximately
45°C, followed by one or more washing steps in 0.2 x SSC, 0.1 % SDS at 50 to 65°C. The skilled worker knows that
these hybridization conditions differ depending on the type of nucleic acid and, for example when organic solvents are
present, regarding temperature and buffer concentration. Under "standard hybridization conditions", for example, the
hybridization temperature is, depending on the type of nucleic acid, between 42°C and 58°C in aqueous buffer with a
concentration of 0.1 to 5 x SSC (pH 7.2). If organic solvents, for example 50% formamide, are present in the above-
mentioned buffer, the temperature under standard conditions is approximately 42°C. The hybridization conditions for
DNA:DNA hybrids, for example, are 0.1 x SSC and 20°C to 45°C, preferably 30°C to 45°C. The hybridization conditions
for DNA:RNA hybrids are, for example, 0.1 x SSC and 30°C to 55°C, preferably 45°C to 55°C. The abovementioned
hybridization conditions are determined by way of example for a nucleic acid with approximately 100 bp (= base pairs)
in length and with a G + C content of 50% in the absence of formamide. The skilled worker knows how to determine the
required hybridization conditions on the basis of the abovementioned textbooks or textbooks such as Sambrook et al.,
"Molecular Cloning", Cold Spring Harbor Laboratory, 1989; Hames and Higgins (Ed.) 1985, "Nucleic Acids Hybridization:
A Practical Approach", IRL Press at Oxford University Press, Oxford; Brown (Ed.) 1991, "Essential Molecular Biology:
A Practical Approach", IRL Press at Oxford University Press, Oxford.
[0020] Furthermore, when the present specification refers to isolated nucleic acid molecules of a nucleotide sequence
which hybridize with one of the nucleotide sequences shown in SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 or with
a part thereof under stringent conditions, "a part thereof’ is understood as meaning, in accordance with the invention,
that at least 25 base pairs (= bp), 50 bp, 75 bp, 100 bp, 125 bp or 150 bp, preferably at least 175 bp, 200 bp, 225 bp,
250 bp, 275 bp or 300 bp, especially preferably 350 bp, 400 bp, 450 bp, 500 bp or more base pairs are used for the
hybridization.
[0021] In the context of the present invention "Homologs" of the ∆5-desaturase nucleic acid sequences with the
sequence SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 means, for example, allelic variants with at least approximately
50 or 60%, preferably at least approximately 60 or 70%, more preferably at least approximately 70 or 80%, 90% or 95%
and even more preferably at least approximately 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95 %, 96%,
97%, 98%, 99% or more identity or homology with a nucleotide sequence shown in SEQ ID NO: 1, SEQ ID NO: 3 or
SEQ ID NO: 5. "Allelic variants" comprise in particular functional variants which can be obtained by deletion, insertion
or substitution of nucleotides from/into the sequence, it being intended, however, that the enzyme activity of the resulting
proteins which are synthesized is advantageously retained for the insertion of one or more genes. "Homologs" also
means bacterial, fungal and plant homologs, truncated sequences, single-stranded DNA or RNA of the coding and
noncoding DNA sequence and derivatives such as, for example, promoter variants. The promoters upstream of the
nucleotide sequences detailed can be modified by one or more nucleotide exchanges, by insertion(s) and/or deletion
(s) without the functionality or activity of the promoters being adversely affected, however. It is furthermore possible that
the modification of the promoter sequence enhances their activity or that they are replaced entirely by more active
promoters, including those from heterologous organisms.
[0022] In order to determine the percentage of homology (= identity) of two amino acid sequences, the sequences
are written one under the other for an optimal comparison (for example, gaps may be introduced into the sequence of
a protein or of a nucleic acid in order to generate an optimal alignment with the other protein or the other nucleic acid).
Then, the amino acid residue or nucleotides at the corresponding amino acid positions or nucleotide positions are
compared. If a position in a sequence is occupied by the same amino acid residue or the same nucleotide as the
corresponding position in the other sequence, then the molecules are homologous at this position (i.e. amino acid or
nucleic acid "homology" as used in the present context corresponds to amino acid or nucleic acid "identity"). The per-
centage of homology between the two sequences is a function of the number of positions which the sequences share
(i.e. % homology = number of identical positions/total number of positions x 100). The terms homology and identity are
therefore to be considered as synonymous.
[0023] The homology was calculated over the entire amino acid or nucleic acid sequence region. The skilled worker
has available a series of programs which are based on various algorithms for the comparison of various sequences.
Here, the algorithms of Needleman and Wunsch or Smith and Waterman give particularly reliable results. The program
PileUp (J. Mol. Evolution., 25, 351-360, 1987, Higgins et al., CABIOS, 5 1989: 151-153) or the programs Gap and BestFit
[Needleman and Wunsch (J. Mol. Biol. 48; 443-453 (1970) and Smith and Waterman (Adv. Appl. Math. 2; 482-489
(1981)], which are part of the GCG software packet [Genetics Computer Group, 575 Science Drive, Madison, Wisconsin,
USA 53711 (1991)], were used for the sequence alignment. The sequence homology values which are indicated above
as a percentage were determined over the entire sequence region using the program GAP and the following settings:
Gap Weight: 50, Length Weight: 3, Average Match: 10.000 and Average Mismatch: 0.000. Unless otherwise specified,
these settings were always used as standard settings for the sequence alignments.
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[0024] In the context of the present invention "∆5-desaturase activity" is understood as meaning that a protein encoded
by a derivative of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 retains an enzymatic activity of at least 10%, preferably
20%, especially preferably 30% and very especially 40% in comparison with the proteins/enzymes encoded by the
sequence SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 and can thus catalyse the reaction of a compound of formula
III to form a compound of formula I.
[0025] In the context of the present invention, the term "thioester linkage" refers to a compound in which the -O- of
an ester group is replaced by a -S-. Thus, in the case where R1 is lysophosphatidylcholine, the free oxygen of the
lysophosphatidyl choline radical may be replaced by sulphur atom such that the linkage to the remainder of the molecule
is via a thioester rather than an ester group. The same also applies to other R1 groups.
[0026] In the context of the present invention, "saturated or unsaturated C2-C24-alkylcarbonyl chain" refers to a sub-
stituted or unsubsituted alkylcarbonyl, alkenylcarbonyl or alkynylcarbonyl group having one or more double and/or triple
bonds. Suitable substituents include hydroxyl or epoxy.
[0027] When R2 or R3 are C2-C24-alkylcarbonyl chains, examples of suitable groups include radicals such as ethyl-
carbonyl, n-propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptylcarbonyl, n-octylcarbonyl, n-
nonylcarbonyl, n-decylcarbonyl, n-undecylcarbonyl, n-dodecylcarbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pen-
tadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcarbonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcar-
bonyl, n-docosanylcarbonyl- or n-tetracosanylcarbonyl, which comprise one or more double bonds.
[0028] Saturated or unsaturated C10-C22-alkylcarbonyl radicals such as n-decylcarbonyl, n-undecylcarbonyl, n-do-
decylcarbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcar-
bonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetra-cosanylcarbonyl,
which comprise one or more double bonds are preferred.
[0029] Especially preferred are saturated and/or unsaturated C10-C22-alkylcarbonyl radicals such as C10-alkylcarbonyl,
C11-alkylcarbonyl, C12-alkylcarbonyl, C13-alkylcarbonyl, C14-alkylcarbonyl, C16-alkylcarbonyl, C18-alkylcarbonyl,
C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds.
[0030] Even more preferred are saturated or unsaturated C16-C22-alkylcarbonyl radicals such as C16-alkylcarbonyl,
C18-alkylcarbonyl, C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds. These
advantageous radicals can comprise two, three, four, five or six double bonds. The especially preferred radicals with 20
or 22 carbon atoms in the fatty acid chain comprise up to six double bonds, advantageously three, four, five or six double
bonds, especially preferably five or six double bonds. All the abovementioned radicals are derived from the corresponding
fatty acids. The substituents R2 or R3 in formula II are advantageously and independently of one another saturated or
unsaturated C18-C22-alkylcarbonyl, especially advantageously they are, independently of one another, unsaturated C18-,
C20- or C22-alkylcarbonyl with at least two double bonds.
[0031] In the compound of general formula (I), it is preferred that the -CH=CH- double bond is in the cis orientation.
[0032] The C10-C18 hydrocarbon chain which forms the group Y may contain up to 4 carbon-carbon double bonds
and these will generally be positioned such that the product of formula I is a non-methylene-interrupted fatty acid.
[0033] In the moiety Y, the carbon-carbon double bonds are preferably in the cis orientation. Preferred Y moieties
include:
-(CH2)4-CH=CH-CH2-CH=CH-(CH2)4-CH3
such that the compound of general formula I is sciadonic acid or a derivative thereof; and
-(CH2)4-CH=CH-CH2-CH=CH-CH2-CH=CH- CH2-CH3
such that the compound of general formula (I) is juniperonic acid or a derivative thereof.
[0034] When Y is one of these moieties, the product can be obtained in any organism which naturally produces linoleic
(C18:2 n-6) or linolenic (C18:3 n-3) acid by genetically modifying that organism to express a ∆9 elongase enzyme as
well as a ∆5-desaturase enzyme. The processes are as follows:
C18:2 n-6 (linoleic acid) is converted by ∆9 elongase to 11,14 C20:2 ; 11,14 C20:2 is converted by ∆5-desaturase
to ∆5cis-11,14-20:3 (SA).
C18:3 n-3 (linolenic acid) is converted by ∆9 elongase to 11,14,17 C20:3 ; 11,14,17 C20:3 is converted by ∆5-
desaturase to ∆5cis-11,14,17-20:4 (JA).
[0035] Therefore, in a second aspect of the invention, there is provided a process for the production of a compound
of general formula (I) as defined above and in which Y is:
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-(CH2)4-CH-CH=CH2-CH=CH-(CH2)4-CH3; or
-(CH2)4-CH=CH-CH2-CH=CH-CH2-CH=CH- CH2-CH3;
in an organism which comprises linoleic (C18:2 n-6) or linolenic (C18:3 n-3) acid, the process comprising introducing
into the organism:
at least one nucleic acid sequence comprising :
a) SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5;
b) a nucleic acid sequence which hybridizes under stringent conditions with a nucleic acid sequence of SEQ
ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5.
c) a nucleic acid sequence which encodes a polypeptide of SEQ ID NO:2, SEQ ID NO: 4 or SEQ ID NO: 6;
d) a derivative of a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 which encodes a
polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO:
6, wherein said polypeptide has ∆5-desaturase activity;
and at least one nucleic acid sequence encoding a polypeptide having ∆9 elongase activity;
and expressing said nucleic acid sequences.
[0036] In the process of this aspect of the invention, the nucleic acid sequence encoding a polypeptide having ∆9
elongase activity may comprise a sequence encoding the C18-∆9 elongase from Isochrysis galbana (SEQ ID NO: 25)
or Acanthamoeba castellanii (SEQ ID NO: 24).
[0037] The processes according to the invention preferably yields total ∆5-unsaturated fatty acids in a content of at
least 1% by weight, advantageously at least 3% by weight, based on the total fatty acids in the transgenic organisms,
preferably in a transgenic plant.
[0038] The fatty acids are advantageously produced in bound form. These ∆5-unsaturated fatty acids can, with the
aid of the nucleic acids used in the process according to the invention, be positioned at the sn1, sn2 and/or sn3 position
of the advantageously produced triglycerides.
[0039] Since a plurality of reaction steps are performed by the starting compounds linoleic acid (C18:2) and linolenic
acid (C18:3) in the process according to the second aspect of invention, the end products of the process such as, for
example, sciadonic acid or juniperonic acid are not obtained as absolutely pure products; minor traces of the precursors
are always present in the end product. If, for example, both linoleic acid and linolenic acid are present in the starting
organism and the starting plant, the end products are present as mixtures.
[0040] Fatty acid esters or fatty acid mixtures produced by the process according to the invention advantageously
comprise 6 to 15% of palmitic acid, 1 to 6% of stearic acid, 7-85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1%
of arachic acid, 7 to 25% of saturated fatty acids, 8 to 85% of monounsaturated fatty acids and 60 to 85% of polyunsaturated
fatty acids, in each case based on 100% and on the total fatty acid content of the organisms. Advantageous polyunsat-
urated fatty acids which are present in the fatty acid esters or fatty acid mixtures are preferably at least 0.1, 0.2, 0.3,
0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1% of arachidonic acid, based on the total fatty acid content. Moreover, the fatty acid esters
or fatty acid mixtures which have been produced by the process of the invention advantageously comprise fatty acids
selected from the group of the fatty acids erucic acid (13-docosaenoic acid), sterculic acid (9,10-methyleneoctadec-9-
enoic acid), malvalic acid (8,9-methyleneheptadec-8-enoic acid), chaulmoogric acid (cyclo-pentenedodecanoic acid),
furan fatty acid (9,12-epoxyoctadeca-9,11-dienoic acid), vernolic acid (9,10-epoxyoctadec-12-enoic acid), tariric acid
(6-octadecynoic acid), 6-nonadecynoic acid, santalbic acid (t11-octadecen-9-ynoic acid), 6,9-octadecenynoic acid, pyru-
lic acid (t10-heptadecen-8-ynoic acid), crepenyninic acid (9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, oc-
tadecen-13-ene-9,11-diynoic acid, petroselenic acid (cis-6-octadecenoic acid), 9c,12t-octadecadienoic acid, calendulic
acid (8t10t12c-octadecatrienoic acid), catalpic acid (9t11 t13c-octadecatrienoic acid), eleostearic acid (9c11 t13t-octa-
decatrienoic acid), jacaric acid (8c10t12c-octadecatrienoic acid), punicic acid (9c11t13c-octadecatrienoic acid), parinaric
acid (9c11t13t15c-octadecatetraenoic acid), pinolenic acid (all-cis-5,9,12-octadecatrienoic acid), laballenic acid (5,6-
octadecadienallenic acid), ricinoleic acid (12-hydroxyoleic acid) and/or coriolic acid (13-hydroxy-9c,11t-octadecadienoic
acid). The abovementioned fatty acids are, as a rule, advantageously only found in traces in the fatty acid esters or fatty
acid mixtures produced by the process according to the invention, that is to say that, based on the total fatty acids, they
occur to less than 30%, preferably to less than 25%, 24%, 23%, 22% or 21%, especially preferably to less than 20%,
15%, 10%, 9%, 8%, 7%, 6% or 5%, very especially preferably to less than 4%, 3%, 2% or 1%. In a further preferred
form of the invention, these abovementioned fatty acids occur to less than 0.9%, 0.8%, 0.7%, 0.6% or 0.5%, especially
preferably to less than 0.4%, 0.3%, 0.2%, 0.1%, based on the total fatty acids. The fatty acid esters or fatty acid mixtures
produced by the process according to the invention advantageously comprise less than 0.1%, based on the total fatty
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acids, and/or no butyric acid, no cholesterol, no clupanodonic acid (= docosapentaenoic acid, C22:5∆4,8,12,15,21) and no
nisinic acid (tetracosahexaenoic acid, C23:6∆3,8,12,15,18,21).
[0041] Chemically pure polyunsaturated fatty acids or fatty acid compositions can also be synthesized by the processes
described above. To this end, the fatty acids or the fatty acid compositions are isolated from the organisms, such as the
microorganisms or the plants or the culture medium in or on which the organisms have been grown, or from the organism
and the culture medium, in the known manner, for example via extraction, distillation, crystallization, chromatography
or a combination of these methods. These chemically pure fatty acids or fatty acid compositions are advantageous for
applications in the food industry sector, the cosmetic sector and especially the pharmacological industry sector.
[0042] Suitable organisms for the production in the process according to the invention are, in principle, any organisms
such as microorganisms, nonhuman animals or plants. Plants which are suitable are, in principle, all those plants which
are capable of synthesizing fatty acids, such as all dicotyledonous or monocotyledonous plants, algae or mosses.
Advantageous plants are selected from the group of the plant families Adelotheciaceae, Anacardiaceae, Asteraceae,
Apiaceae, Betulaceae, Boraginaceae, Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae,
Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae, Euphorbiaceae, Fa-
baceae, Geraniaceae, Gramineae, Juglandaceae, Lauraceae, Leguminosae, Linaceae, Euglenaceae, Prasinophyceae
or vegetable plants or ornamentals such as Tagetes.
[0043] Examples which may be mentioned are the following plants selected from the group consisting of: Adelothe-
ciaceae such as the genera Physcomitrella, for example the genus and species Physcomitrella patens, Anacardiaceae
such as the genera Pistacia, Mangifera, Anacardium, for example the genus and species Pistacia vera [pistachio],
Mangifer indica [mango] or Anacardium occidentale [cashew], Asteraceae, such as the genera Calendula, Carthamus,
Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana, for example the genus and species
Calendula officinalis [common marigold], Carthamus tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium
intybus [chicory], Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca sativa, Lactuca crispa, Lactuca
esculenta, Lactuca scariola L. ssp. sativa, Lactuca scariola L. var. integrata, Lactuca scariola L. var. integrifolia, Lactuca
sativa subsp. romana, Locusta communis, Valeriana locusta [salad vegetables], Tagetes lucida, Tagetes erecta or
Tagetes tenuifolia [african or french marigold], Apiaceae, such as the genus Daucus, for example the genus and species
Daucus carota [carrot], Betulaceae, such as the genus Corylus, for example the genera and species Corylus avellana
or Corylus colurna [hazelnut], Boraginaceae, such as the genus Borago, for example the genus and species Borago
officinalis [borage], Brassicaceae, such as the genera Brassica, Camelina, Melanosinapis, Sinapis,
[0044] Arabadopsis, for example the genera and species Brassica napus, Brassica rapa ssp. [oilseed rape], Sinapis
arvensis Brassica juncea, Brassica juncea var. juncea, Brassica juncea var. crispifolia, Brassica juncea var. foliosa,
Brassica nigra, Brassica sinapioides, Camelina sativa, Melanosinapis communis [mustard], Brassica oleracea [fodder
beet] or Arabidopsis thaliana, Bromeliaceae, such as the genera Anana, Bromelia (pineapple), for example the genera
and species Anana comosus, Ananas ananas or Bromelia comosa [pineapple], Caricaceae, such as the genus Carica,
such as the genus and species Carica papaya [pawpaw], Cannabaceae, such as the genus Cannabis, such as the
genus and species Cannabis sativa [hemp], Convolvulaceae, such as the genera Ipomea, Convolvulus, for example the
genera and species Ipomoea batatus, Ipomoea pandurata, Convolvulus batatas, Convolvulus tiliaceus, Ipomoea fas-
tigiata, Ipomoea tiliacea, Ipomoea triloba or Convolvulus panduratus [sweet potato, batate], Chenopodiaceae, such as
the genus Beta, such as the genera and species Beta vulgaris, Beta vulgaris var. altissima, Beta vulgaris var. vulgaris,
Beta maritima, Beta vulgaris var. perennis, Beta vulgaris var. conditiva or Beta vulgaris var. esculenta [sugarbeet],
Crypthecodiniaceae, such as the genus Crypthecodinium, for example the genus and species Cryptecodinium cohnii,
Cucurbitaceae, such as the genus Cucurbita, for example the genera and species Cucurbita maxima, Cucurbita mixta,
Cucurbita pepo or Cucurbita moschata [pumpkin/squash], Cymbellaceae, such as the genera Amphora, Cymbella,
Okedenia, Phaeodactylum, Reimeria, for example the genus and species Phaeodactylum tricornutum, Ditrichaceae,
such as the genera Ditrichaceae, Astomiopsis, Ceratodon, Chrysoblastella, Ditrichum, Distichium, Eccremidium, Lo-
phidion, Philibertiella, Pleuridium, Saelania, Trichodon, Skottsbergia, for example the genera and species Ceratodon
antarcticus, Ceratodon columbiae, Ceratodon heterophyllus, Ceratodon purpurascens, Ceratodon purpureus, Ceratodon
purpureus ssp. convolutus, Ceratodon purpureus ssp. stenocarpus, Ceratodon purpureus var. rotundifolius, Ceratodon
ratodon, Ceratodon stenocarpus, Chrysoblastella chilensis, Ditrichum ambiguum, Ditrichum brevisetum, Ditrichum
crispatissimum, Ditrichum difficile, Ditrichum falcifolium, Ditrichum flexicaule, Ditrichum giganteum, Ditrichum hetero-
mallum, Ditrichum lineare, Ditrichum lineare, Ditrichum montanum, Ditrichum montanum, Ditrichum pallidum, Ditrichum
punctulatum, Ditrichum pusillum, Ditrichum pusillum var. tortile, Ditrichum rhynchostegium, Ditrichum schimperi, Ditri-
chum tortile, Distichium capillaceum, Distichium hagenii, Distichium inclinatum, Distichium macounii, Eccremidium flor-
idanum, Eccremidium whiteleggei, Lophidion strictus, Pleuridium acuminatum, Pleuridium alternifolium, Pleuridium hold-
ridgei, Pleuridium mexicanum, Pleuridium ravenelii, Pleuridium subulatum, Saelania glaucescens, Trichodon borealis,
Trichodon cylindricus or Trichodon cylindricus var. oblongus, Elaeagnaceae, such as the genus Elaeagnus, for example
the genus and species Olea europaea [olive], Ericaceae, such as the genus Kalmia, for example the genera and species
Kalmia latifolia, Kalmia angustifolia, Kalmia microphylla, Kalmia polifolia, Kalmia occidentalis, Cistus chamaerhodendros
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or Kalmia lucida [mountain laurel], Euglenaceae, such as the genera Ascoglena, Astasia, Colacium, Cyclidiopsis, Eu-
glena, Euglenopsis, Hyalaphacus, Khawkinea, Lepocinclis, Phacus, Strombomonas, Trachelomonas, for example the
genus and species Euglena gracilis; Euphorbiaceae, such as the genera Manihot, Janipha, Jatropha, Ricinus, for example
the genera and species Manihot utilissima, Janipha manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot
manihot, Manihot melanobasis, Manihot esculenta [cassava] or Ricinus communis [castor-oil plant], Fabaceae, such as
the genera Pisum, Albizia, Cathormion, Feuillea, Inga, Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos,
Phaseolus, soybean, for example the genera and species Pisum sativum, Pisum arvense, Pisum humile [pea], Albizia
berteriana, Albizia julibrissin, Albizia lebbeck, Acacia berteriana, Acacia littoralis, Albizia berteriana, Albizzia berteriana,
Cathormion berteriana, Feuillea berteriana, Inga fragrans, Pithecellobium berterianum, Pithecellobium fragrans,
Pithecolobium berterianum, Pseudalbizzia berteriana, Acacia julibrissin, Acacia nemu, Albizia nemu, Feuilleea julibrissin,
Mimosa julibrissin, Mimosa speciosa, Sericanrda julibrissin, Acacia lebbeck, Acacia macrophylla, Albizia lebbeck, Feuil-
leea lebbeck, Mimosa lebbeck, Mimosa speciosa, Medicago sativa, Medicago falcata, Medicago varia [alfalfa] Glycine
max Dolichos soja, Glycine gracilis, Glycine hispida, Phaseolus max, Soja hispida or Soja max [soybean], Funariaceae,
such as the genera Aphanorrhegma, Entosthodon, Funaria, Physcomitrella, Physcomitrium, for example the genera
and species Aphanorrhegma serratum, Entosthodon attenuatus, Entosthodon bolanderi, Entosthodon bonplandii, En-
tosthodon californicus, Entosthodon drummondii, Entosthodon jamesonii, Entosthodon leibergii, Entosthodon neoscoti-
cus, Entosthodon rubrisetus, Entosthodon spathulifolius, Entosthodon tucsoni, Funaria americana, Funaria bolanderi,
Funaria calcarea, Funaria californica, Funaria calvescens, Funaria convoluta, Funaria flavicans, Funaria groutiana,
Funaria hygrometrica, Funaria hygrometrica var. arctica, Funaria hygrometrica var. calvescens, Funaria hygrometrica
var. convoluta, Funaria hygrometrica var. muralis, Funaria hygrometrica var. utahensis, Funaria microstoma, Funaria
microstoma var. obtusifolia, Funaria muhlenbergii, Funaria orcuttii, Funaria plano-convexa, Funaria polaris, Funaria
ravenelii, Funaria rubriseta, Funaria serrata, Funaria sonorae, Funaria sublimbatus, Funaria tucsoni, Physcomitrella
californica, Physcomitrella patens, Physcomitrella readeri, Physcomitrium australe, Physcomitrium californicum, Phys-
comitrium collenchymatum, Physcomitrium coloradense, Physcomitrium cupuliferum, Physcomitrium drummondii, Phys-
comitrium eurystomum, Physcomitrium flexifolium, Physcomitrium hookeri, Physcomitrium hookeri var. serratum, Phys-
comitrium immersum, Physcomitrium kellermanii, Physcomitrium megalocarpum, Physcomitrium pyriforme, Physcomitri-
um pyriforme var. serratum, Physcomitrium rufipes, Physcomitrium sandbergii, Physcomitrium subsphaericum, Phys-
comitrium washingtoniense, Geraniaceae, such as the genera Pelargonium, Cocos, Oleum, for example the genera and
species Cocos nucifera, Pelargonium grossularioides or Oleum cocois [coconut], Gramineae, such as the genus Sac-
charum, for example the genus and species Saccharum officinarum, Juglandaceae, such as the genera Juglans, Wallia,
for example the genera and species Juglans regia, Juglans ailanthifolia, Juglans sieboldiana, Juglans cinerea, Wallia
cinerea, Juglans bixbyi, Juglans californica, Juglans hindsii, Juglans intermedia, Juglans jamaicensis, Juglans major,
Juglans microcarpa, Juglans nigra or Wallia nigra [walnut], Lauraceae, such as the genera Persea, Laurus, for example
the genera and species Laurus nobilis [bay], Persea americana, Persea gratissima or Persea persea [avocado], Legu-
minosae, such as the genus Arachis, for example the genus and species Arachis hypogaea [peanut], Linaceae, such
as the genera Adenolinum, for example the genera and species Linum usitatissimum, Linum humile, Linum austriacum,
Linum bienne, Linum angustifolium, Linum catharticum, Linum flavum, Linum grandiflorum, Adenolinum grandiflorum,
Linum lewisii, Linum narbonense, Linum perenne, Linum perenne var. lewisii, Linum pratense or Linum trigynum [linseed],
Lythrarieae, such as the genus Punica, for example the genus and species Punica granatum [pomegranate], Malvaceae,
such as the genus Gossypium, for example the genera and species Gossypium hirsutum, Gossypium arboreum, Gos-
sypium barbadense, Gossypium herbaceum or Gossypium thurberi [cotton], Marchantiaceae, such as the genus March-
antia, for example the genera and species Marchantia berteroana, Marchantia foliacea, Marchantia macropora, Musace-
ae, such as the genus Musa, for example the genera and species Musa nana, Musa acuminata, Musa paradisiaca,
Musa spp. [banana], Onagraceae, such as the genera Camissonia, Oenothera, for example the genera and species
Oenothera biennis or Camissonia brevipes [evening primrose], Palmae, such as the genus Elaeis, for example the genus
and species Elaeis guineensis [oil palm], Papaveraceae, such as, for example, the genus Papaver, for example the
genera and species Papaver orientale, Papaver rhoeas, Papaver dubium [poppy], Pedaliaceae, such as the genus
Sesamum, for example the genus and species Sesamum indicum [sesame], Piperaceae, such as the genera Piper,
Artanthe, Peperomia, Steffensia, for example the genera and species Piper aduncum, Piper amalago, Piper angustifolium,
Piper auritum, Piper betel, Piper cubeba, Piper longum, Piper nigrum, Piper retrofractum, Artanthe adunca, Artanthe
elongata, Peperomia elongata, Piper elongatum, Steffensia elongata [cayenne pepper], Poaceae, such as the genera
Hordeum, Secale, Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza, Zea (maize), Triticum, for example the
genera and species Hordeum vulgare, Hordeum jubatum, Hordeum murinum, Hordeum secalinum, Hordeum distichon
Hordeum aegiceras, Hordeum hexastichon, Hordeum hexastichum, Hordeum irregulare, Hordeum sativum, Hordeum
secalinum [barley], Secale cereale [rye], Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena
hybrida [oats], Sorghum bicolor, Sorghum halepense, Sorghum saccharatum, Sorghum vulgare, Andropogon drummon-
dii, Holcus bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum arundinaceum, Sorghum caffrorum, Sorghum
cernuum, Sorghum dochna, Sorghum drummondii, Sorghum durra, Sorghum guineense, Sorghum lanceolatum, Sor-
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ghum nervosum, Sorghum saccharatum, Sorghum subglabrescens, Sorghum verticilliflorum, Sorghum vulgare, Holcus
halepensis, Sorghum miliaceum, Panicum militaceum [millet], Oryza sativa, Oryza latifolia [rice], Zea mays [maize]
Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum or Triticum
vulgare [wheat], Porphyridiaceae, such as the genera Chroothece, Flintiella, Petrovanella, Porphyridium, Rhodella,
Rhodosorus, Vanhoeffenia, for example the genus and species Porphyridium cruentum, Proteaceae, such as the genus
Macadamia, for example the genus and species Macadamia intergrifolia [macadamia], Prasinophyceae, such as the
genera Nephroselmis, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, for example the genera and
species Nephroselmis olivacea, Prasinococcus capsulatus, Scherffelia dubia, Tetraselmis chui, Tetraselmis suecica,
Mantoniella squamata, Ostreococcus tauri, Rubiaceae, such as the genus Coffea, for example the genera and species
Coffea spp., Coffea arabica, Coffea canephora or Coffea liberica [coffee], Scrophulariaceae, such as the genus Ver-
bascum, for example the genera and species Verbascum blattaria, Verbascum chaixii, Verbascum densiflorum, Ver-
bascum lagurus, Verbascum longifolium, Verbascum lychnitis, Verbascum nigrum, Verbascum olympicum, Verbascum
phlomoides, Verbascum phoenicum, Verbascum pulverulentum or Verbascum thapsus [verbascum], Solanaceae, such
as the genera Capsicum, Nicotiana, Solanum, Lycopersicon, for example the genera and species Capsicum annuum,
Capsicum annuum var. glabriusculum, Capsicum frutescens [pepper], Capsicum annuum [paprika], Nicotiana tabacum,
Nicotiana alata, Nicotiana attenuata, Nicotiana glauca, Nicotiana langsdorffii, Nicotiana obtusifolia, Nicotiana quadri-
valvis, Nicotiana repanda, Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum tuberosum [potato], Solanum me-
longena [eggplant] Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum integrifo-
lium or Solanum lycopersicum [tomato], Sterculiaceae, such as the genus Theobroma, for example the genus and
species Theobroma cacao [cacao] or Theaceae, such as the genus Camellia, for example the genus and species
Camellia sinensis [tea].
[0045] Advantageous microorganisms are, for example, fungi selected from the group of the families Chaetomiaceae,
Choanephoraceae, Cryptococcaceae, Cunninghamellaceae, Demetiaceae, Moniliaceae, Mortierellaceae, Mucoraceae,
Pythiaceae, Sacharomycetaceae, Saprolegniaceae, Schizosacharomycetaceae, Sodariaceae or Tuberculariaceae.
[0046] Examples of microorganisms which may be mentioned are those from the groups: Choanephoraceae, such
as the genera Blakeslea, Choanephora, for example the genera and species Blakeslea trispora, Choanephora cucur-
bitarum, Choanephora infundibulifera var. cucurbitarum, Mortierellaceae, such as the genus Mortierella, for example
the genera and species Mortierella isabellina, Mortierella polycephala , Mortierella ramanniana , Mortierella vinacea,
Mortierella zonata, Pythiaceae, such as the genera Phytium, Phytophthora, for example the genera and species Pythium
debaryanum, Pythium intermedium, Pythium irregulare, Pythium megalacanthum, Pythium paroecandrum, Pythium
sylvaticum, Pythium ultimum, Phytophthora cactorum, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora
citrophthora, Phytophthora cryptogea, Phytophthora drechsleri, Phytophthora erythroseptica, Phytophthora lateralis,
Phytophthora megasperma, Phytophthora nicotianae, Phytophthora nicotianae var. parasitica, Phytophthora palmivora,
Phytophthora parasitica, Phytophthora syringae, Saccharomycetaceae, such as the genera Hansenula, Pichia, Sac-
charomyces, Saccharomycodes, Yarrowia, for example the genera and species Hansenula anomala, Hansenula cali-
fornica, Hansenula canadensis, Hansenula capsulata, Hansenula ciferrii, Hansenula glucozyma, Hansenula henricii,
Hansenula holstii, Hansenula minuta, Hansenula nonfermentans, Hansenula philodendri, Hansenula polymorpha,
Hansenula saturnus, Hansenula subpelliculosa, Hansenula wickerhamii, Hansenula wingei, Pichia alcoholophila, Pichia
angusta, Pichia anomala, Pichia bispora, Pichia burtonii, Pichia canadensis, Pichia capsulata, Pichia carsonii, Pichia
cellobiosa, Pichia ciferrii, Pichia farinosa, Pichia fermentans, Pichia finlandica, Pichia glucozyma, Pichia guilliermondii,
Pichia haplophila, Pichia henricii, Pichia holstii, Pichia jadinii, Pichia lindnerii, Pichia membranaefaciens, Pichia meth-
anolica, Pichia minuta var. minuta, Pichia minuta var. nonfermentans, Pichia norvegensis, Pichia ohmeri, Pichia pastoris,
Pichia philodendri, Pichia pini, Pichia polymorpha, Pichia quercuum, Pichia rhodanensis, Pichia sargentensis, Pichia
stipitis, Pichia strasburgensis, Pichia subpelliculosa, Pichia toletana, Pichia trehalophila, Pichia vini, Pichia xylosa, Sac-
charomyces aceti, Saccharomyces bailii, Saccharomyces bayanus, Saccharomyces bisporus, Saccharomyces capen-
sis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces cerevisiae var. ellipsoideus, Saccha-
romyces chevalieri, Saccharomyces delbrueckii, Saccharomyces diastaticus, Saccharomyces drosophilarum, Saccha-
romyces elegans, Saccharomyces ellipsoideus, Saccharomyces fermentati, Saccharomyces florentinus, Saccharomy-
ces fragilis, Saccharomyces heterogenicus, Saccharomyces hienipiensis, Saccharomyces inusitatus, Saccharomyces
italicus, Saccharomyces kluyveri, Saccharomyces krusei, Saccharomyces lactis, Saccharomyces marxianus, Saccha-
romyces microellipsoides, Saccharomyces montanus, Saccharomyces norbensis, Saccharomyces oleaceus, Saccha-
romyces paradoxus, Saccharomyces pastorianus, Saccharomyces pretoriensis, Saccharomyces rosei, Saccharomyces
rouxii, Saccharomyces uvarum, Saccharomycodes ludwigii, Yarrowia lipolytica, Schizosacharomycetaceae such as the
genera Schizosaccharomyces e.g. the species Schizosaccharomyces japonicus var. japonicus, Schizosaccharomyces
japonicus var. versatilis, Schizosaccharomyces malidevorans, Schizosaccharomyces octosporus, Schizosaccharomy-
ces pombe var. malidevorans, Schizosaccharomyces pombe var. pombe, Thraustochytriaceae such as the genera
Althornia, Aplanochytrium, Japonochytrium, Schizochytrium, Thraustochytrium e.g. the species Schizochytrium aggre-
gatum, Schizochytrium limacinum, Schizochytrium mangrovei, Schizochytrium minutum, Schizochytrium octosporum,
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Thraustochytrium aggregatum, Thraustochytrium amoeboideum, Thraustochytrium antacticum, Thraustochytrium aru-
dimentale, Thraustochytrium aureum, Thraustochytrium benthicola, Thraustochytrium globosum, Thraustochytrium in-
dicum, Thraustochytrium kerguelense, Thraustochytrium kinnei, Thraustochytrium motivum, Thraustochytrium multiru-
dimentale, Thraustochytrium pachydermum, Thraustochytrium proliferum, Thraustochytrium roseum, Thraustochytrium
rossii, Thraustochytrium striatum or Thraustochytrium visurgense.
[0047] Further advantageous microorganisms are, for example, bacteria selected from the group of the families Bacil-
laceae, Enterobacteriacae or Rhizobiaceae.
[0048] Examples which may be mentioned are the following microorganisms selected from the group consisting of:
Bacillaceae, such as the genus Bacillus, for example the genera and species Bacillus acidocaldarius, Bacillus acidoter-
restris, Bacillus alcalophilus, Bacillus amyloliquefaciens, Bacillus amylolyticus, Bacillus brevis, Bacillus cereus, Bacillus
circulans, Bacillus coagulans, Bacillus sphaericus subsp. fusiformis, Bacillus galactophilus, Bacillus globisporus, Bacillus
globisporus subsp. marinus, Bacillus halophilus, - Bacillus lentimorbus, Bacillus lentus, Bacillus licheniformis, Bacillus
megaterium, Bacillus polymyxa, Bacillus psychrosaccharolyticus, Bacillus pumilus, Bacillus sphaericus, Bacillus subtilis
subsp. spizizenii, Bacillus subtilis subsp. subtilis or Bacillus thuringiensis; Enterobacteriacae such as the genera Citro-
bacter, Edwardsiella, Enterobacter, Erwinia, Escherichia, Klebsiella, Salmonella or Serratia, for example the genera and
species Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Citrobacter genomospecies, Citrobacter
gillenii, Citrobacter intermedium, Citrobacter koseri, Citrobacter murliniae, Citrobacter sp., Edwardsiella hoshinae, Ed-
wardsiella ictaluri, Edwardsiella tarda, Erwinia alni, Erwinia amylovora, Erwinia ananatis, Erwinia aphidicola, Erwinia
billingiae, Erwinia cacticida, Erwinia cancerogena, Erwinia carnegieana, Erwinia carotovora subsp. atroseptica, Erwinia
carotovora subsp. betavasculorum, Erwinia carotovora subsp. odorifera, Erwinia carotovora subsp. wasabiae, Erwinia
chrysanthemi, Erwinia cypripedii, Erwinia dissolvens, Erwinia herbicola, Erwinia mallotivora, Erwinia milletiae, Erwinia
nigrifluens, Erwinia nimipressuralis, Erwinia persicina, Erwinia psidii, Erwinia pyrifoliae, Erwinia quercina, Erwinia rhapon-
tici, Erwinia. rubrifaciens, Erwinia salicis, Erwinia stewartii, Erwinia tracheiphila, Erwinia uredovora, Escherichia adecar-
boxylata, Escherichia anindolica, Escherichia aurescens, Escherichia blattae, Escherichia coli, Escherichia coli var.
communior, Escherichia coli-mutabile, Escherichia fergusonii, Escherichia hermannii, Escherichia sp., Escherichia vul-
neris, Klebsiella aerogenes, Klebsiella edwardsii subsp. atlantae, Klebsiella ornithinolytica, Klebsiella oxytoca, Klebsiella
planticola, Klebsiella pneumoniae, Klebsiella pneumoniae subsp. pneumoniae, Klebsiella sp., Klebsiella terrigena, Kleb-
siella trevisanii, Salmonella abony, Salmonella arizonae, Salmonella bongori, Salmonella choleraesuis subsp. arizonae,
Salmonella choleraesuis subsp. bongori, Salmonella choleraesuis subsp. cholereasuis, Salmonella choleraesuis subsp.
diarizonae, Salmonella choleraesuis subsp. houtenae, Salmonella choleraesuis subsp. indica, Salmonella choleraesuis
subsp. salamae, Salmonella daressalaam, Salmonella enterica subsp. houtenae, Salmonella enterica subsp. salamae,
Salmonella enteritidis, Salmonella gallinarum, Salmonella heidelberg, Salmonella panama, Salmonella senftenberg,
Salmonella typhimurium, Serratia entomophila, Serratia ficaria, Serratia fonticola, Serratia grimesii, Serratia liquefaciens,
Serratia marcescens, Serratia marcescens subsp. marcescens, Serratia marinorubra, Serratia odorifera, Serratia ply-
mouthensis, Serratia plymuthica, Serratia proteamaculans, Serratia proteamaculans subsp. quinovora, Serratia quini-
vorans or Serratia rubidaea; Rhizobiaceae, such as the genera Agrobacterium, Carbophilus, Chelatobacter, Ensifer,
Rhizobium, Sinorhizobium, for example the genera and species Agrobacterium atlanticum, Agrobacterium ferrugineum,
Agrobacterium gelatinovorum, Agrobacterium larrymoorei, Agrobacterium meteori, Agrobacterium radiobacter, Agro-
bacterium rhizogenes, Agrobacterium rubi, Agrobacterium stellulatum, Agrobacterium tumefaciens, Agrobacterium vitis,
Carbophilus carboxidus, Chelatobacter heintzii, Ensifer adhaerens, Ensifer arboris, Ensifer fredii, Ensifer kostiensis,
Ensifer kummerowiae, Ensifer medicae, Ensifer meliloti, Ensifer saheli, Ensifer terangae, Ensifer xinjiangensis, Rhizo-
bium ciceri Rhizobium etli, Rhizobium fredii, Rhizobium galegae, Rhizobium gallicum, Rhizobium giardinii, Rhizobium
hainanense, Rhizobium huakuii, Rhizobium huautlense, Rhizobium indigoferae, Rhizobium japonicum, Rhizobium le-
guminosarum, Rhizobium loessense, Rhizobium loti, Rhizobium lupini, Rhizobium mediterraneum, Rhizobium meliloti,
Rhizobium mongolense, Rhizobium phaseoli, Rhizobium radiobacter, Rhizobium rhizogenes, Rhizobium rubi, Rhizobium
sullae, Rhizobium tianshanense, Rhizobium trifolii, Rhizobium tropici, Rhizobium undicola, Rhizobium vitis, Sinorhizo-
bium adhaerens, Sinorhizobium arboris, Sinorhizobium fredii, Sinorhizobium kostiense, Sinorhizobium kummerowiae,
Sinorhizobium medicae, Sinorhizobium meliloti, Sinorhizobium morelense, Sinorhizobium saheli or Sinorhizobium xin-
jiangense.
[0049] Further examples of advantageous microorganisms for the process according to the invention are protists or
diatoms selected from the group of the families Dinophyceae, Turaniellidae or Oxytrichidae, such as the genera and
species: Crypthecodinium cohnii, Phaeodactylum tricornutum, Stylonychia mytilus, Stylonychia pustulata, Stylonychia
putrina, Stylonychia notophora, Stylonychia sp., Colpidium campylum or Colpidium sp. Those which are advantageously
applied in the process according to the invention are transgenic organisms such as fungi, such as mortierella or thraus-
trochytrium, yeasts such as Saccharomyces or Schizosaccharomyces, mosses such as Physcomitrella or Ceratodon,
nonhuman animals such as Caenorhabditis, algae such as Nephroselmis, Pseudoscourfielda, Prasinococcus, Scherf-
felia, Tetraselmis, Mantoniella, Ostreococcus, Crypthecodinium or Phaeodactylum or plants such as dicotyledonous or
monocotyledonous plants. Organisms which are especially advantageously used in the process according to the invention
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are organisms which belong to the oil-producing organisms, that is to say which are used for the production of oil, such
as fungi, such as Mortierella or Thraustochytrium, algae such as Nephroselmis, Pseudoscourfielda, Prasinococcus,
Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, Crypthecodinium, Phaeodactylum, or plants, in particular plants,
preferably oilseed or oil crop plants which comprise large amounts of lipid compounds, such as peanut, oilseed rape,
canola, sunflower, safflower (Carthamus tinctoria), poppy, mustard, hemp, castor-oil plant, olive, sesame, Calendula,
Punica, evening primrose, verbascum, thistle, wild roses, hazelnut, almond, macadamia, avocado, bay, pumpkin/squash,
linseed, soybean, pistachios, borage, trees (oil palm, coconut or walnut) or arable crops such as maize, wheat, rye, oats,
triticale, rice, barley, cotton, cassava, pepper, Tagetes, Solanaceae plants such as potato, tobacco, eggplant and tomato,
Vicia species, pea, alfalfa or bushy plants (coffee, cacao, tea), Salix species, and perennial grasses and fodder crops.
Preferred plants according to the invention are oil crop plants such as peanut, oilseed rape, canola, sunflower, safflower,
poppy, mustard, hemp, castor-oil plant, olive, Calendula, Punica, evening primrose, pumpkin/squash, linseed, soybean,
borage, trees (oil palm, coconut). Especially preferred for the second aspect of the invention are plants which are high
in C18:2- and/or C18:3-fatty acids, such as sunflower, safflower, tobacco, verbascum, sesame, cotton, pumpkin/squash,
poppy, evening primrose, walnut, linseed, hemp or thistle. Very especially preferred plants are plants such as safflower,
sunflower, poppy, evening primrose, walnut, linseed or hemp.
[0050] It is also be advantageous for the above-described method according to the invention additionally to introduce,
into the organism, further nucleic acids which encode enzymes of the fatty acid or lipid metabolism, in addition to the
nucleic acids introduced in the processes of the first and second aspects of the invention.
[0051] Nucleic acids used in the process according to the invention are advantageously derived from plants such as
algae, for example algae of the family of the Prasinophyceae such as the genera Heteromastix, Mammella, Mantoniella,
Micromonas, Nephroselmis, Ostreococcus, Prasinocladus, Prasinococcus, Pseudoscourfielda, Pycnococcus, Pyrami-
monas, Scherffelia or Tetraselmis such as the genera and species Heteromastix longifillis, Mamiella gilva, Mantoniella
squamata, Micromonas pusilla, Nephroselmis olivacea, Nephroselmis pyriformis, Nephroselmis rotunda, Ostreococcus
tauri, Ostreococcus sp. Prasinocladus ascus, Prasinocladus lubricus, Pycnococcus provasolii, Pyramimonas amylifera,
Pyramimonas disomata, Pyramimonas obovata, Pyramimonas orientalis, Pyramimonas parkeae, Pyramimonas spinif-
era, Pyramimonas sp., Tetraselmis apiculata, Tetraselmis carteriaformis, Tetraselmis chui, Tetraselmis convolutae,
Tetraselmis desikacharyi, Tetraselmis gracilis, Tetraselmis hazeni, Tetraselmis impellucida, Tetraselmis inconspicua,
Tetraselmis levis, Tetraselmis maculata, Tetraselmis marina, Tetraselmis striata, Tetraselmis subcordiformis, Tet-
raselmis suecica, Tetraselmis tetrabrachia, Tetraselmis tetrathele, Tetraselmis verrucosa, Tetraselmis verrucosa fo.
rubens or Tetraselmis sp. or from algae of the family Euglenaceae such as the genera Ascoglena, Astasia, Colacium,
Cyclidiopsis, Euglena, Euglenopsis, Hyalophacus, Khawkinea, Lepocinclis, Phacus, Strombomonas or Trachelomonas,
such as the genera and species Euglena acus, Euglena geniculata, Euglena gracilis, Euglena mixocylindracea, Euglena
rostrifera, Euglena viridis, Colacium stentorium, Trachelomonas cylindrica or Trachelomonas volvocina. The nucleic
acids used are advantageously derived from algae of the genera Euglena, Mantoniella or Ostreococcus.
[0052] Further advantageous plants are algae such as Isochrysis or Crypthecodinium, algae/diatoms such as Tha-
lassiosira or Phaeodactylum, mosses such as Physcomitrella or Ceratodon, or higher plants such as the Primulaceae
such as Aleuritia, Calendula stellata, Osteospermum spinescens or Osteospermum hyoseroides, microorganisms such
as fungi, such as Aspergillus, Thraustochytrium, Phytophthora, Entomophthora, Mucor or Mortierella, bacteria such as
Shewanella, yeasts or animals such as nematodes such as Caenorhabditis, insects, frogs, abalone, or fish. The isolated
nucleic acid sequences according to the invention are advantageously derived from an animal of the order of the ver-
tebrates. Preferably, the nucleic acid sequences are derived from the classes of the Vertebrata; Euteleostomi, Actinop-
terygii; Neopterygii; Teleostei; Euteleostei, Protacanthopterygii, Salmoniformes; Salmonidae or Oncorhynchus or Ver-
tebrata, Amphibia, Anura, Pipidae, Xenopus or Evertebrata such as Protochordata, Tunicata, Holothuroidea, Cionidae
such as Amaroucium constellatum, Botryllus schlosseri, Ciona intestinalis, Molgula citrina, Molgula manhattensis, Per-
ophora viridis or Styela partita. The nucleic acids are especially advantageously derived from fungi, animals, or from
plants such as algae or mosses, preferably from the order of the Salmoniformes, such as the family of the Salmonidae,
such as the genus Salmo, for example from the genera and species Oncorhynchus mykiss, Trutta trutta or Salmo trutta
fario, from algae, such as the genera Mantoniella or Ostreococcus, or from the diatoms such as the genera Thalassiosira
or Phaeodactylum or from algae such as Crypthecodinium.
[0053] In a preferred embodiment, the process furthermore comprises the step of obtaining a cell or an intact organism
which comprises the nucleic acid sequences used in the process, where the cell and/or the organism is transformed
with a nucleic acid sequence according to the invention which encodes the ∆5-desaturase, a gene construct or a vector
as described above, alone or in combination with further nucleic acid sequences which encode proteins of the fatty acid
or lipid metabolism. In a further preferred embodiment, this process furthermore comprises the step of obtaining the oils,
lipids or free fatty acids from the organism or from the culture. The culture can, for example, take the form of a fermentation
culture, for example in the case of the cultivation of microorganisms, such as, for example, Mortierella, Thalassiosira,
Mantoniella, Ostreococcus, Saccharomyces or Thraustochytrium, or a greenhouse- or field-grown culture of a plant.
The cell or the organism produced thus is advantageously a cell of an oil-producing organism, such as an oil crop, such
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as, for example, peanut, oilseed rape, canola, linseed, hemp, peanut, soybean, safflower, hemp, sunflowers or borage.
[0054] In the case of plant cells, plant tissue or plant organs, "growing" is understood as meaning, for example, the
cultivation on or in a nutrient medium, or of the intact plant on or in a substrate, for example in a hydroponic culture,
potting compost or on arable land.
[0055] For the purposes of the invention, "transgenic" or "recombinant" means with regard to, for example, a nucleic
acid sequence, an expression cassette (= gene construct) or a vector comprising the nucleic acid sequence or an
organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all
those constructions brought about by recombinant methods in which either
a) the nucleic acid sequence according to the invention, or
b) a genetic control sequence which is operably linked with the nucleic acid sequence according to the invention,
for example a promoter, or
c) a) and b)
are not located in their natural genetic environment or have been modified by recombinant methods, it being possible
for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or
more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromo-
somal locus in the original organism or the presence in a genomic library. In the case of a genomic library, the natural
genetic environment of the nucleic acid sequence is preferably retained, at least in part. The environment flanks the
nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp,
especially preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette - for
example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding
∆5-desaturase gene - becomes a transgenic expression cassette when this expression cassette is modified by non-
natural, synthetic ("artificial") methods such as, for example, mutagenic treatment. Suitable methods are described, for
example, in US 5,565,350 or WO 00/15815.
[0056] A transgenic organism or transgenic plant for the purposes of the invention is therefore understood as meaning,
as above, that the nucleic acids used in the process are not at their natural locus in the genome of an organism, it being
possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also
means that, while the nucleic acids according to the invention are at their natural position in the genome of an organism,
the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural
sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids
according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression
of the nucleic acids takes place. Preferred transgenic organisms are fungi such as Mortierella or Phytophtora, mosses
such as Physcomitrella, algae such as Mantoniella, Euglena, Crypthecodinium or Ostreococcus, diatoms such as Tha-
lassiosira or Phaeodactylum, or plants such as the oil crops.
[0057] Organisms or host organisms for the nucleic acids, the expression cassette or the vector used in the process
according to the invention are, in principle, advantageously all organisms which are capable of synthesizing fatty acids,
specifically unsaturated fatty acids, and/or which are suitable for the expression of recombinant genes. Examples which
may be mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or crop plants such as soybean,
peanut, castor-oil plant, sunflower, maize, cotton, flax, oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius)
or cacao bean, microorganisms, such as fungi, for example the genus Mortierella, Thraustochytrium, Saprolegnia,
Phytophtora or Pythium, bacteria, such as the genus Escherichia or Shewanella, yeasts, such as the genus Saccharo-
myces, cyanobacteria, ciliates, algae such as Mantoniella, Euglena, Thalassiosira or Ostreococcus, or protozoans such
as dinoflagellates, such as Crypthecodinium. Preferred organisms are those which are naturally capable of synthesizing
substantial amounts of oil, such as fungi, such as Mortierella alpina, Pythium insidiosum, Phytophtora infestans, or plants
such as soybean, oilseed rape, coconut, oil palm, safflower, flax, hemp, castor-oil plant, Calendula, peanut, cacao bean
or sunflower, or yeasts such as Saccharomyces cerevisiae with soybean, flax, oilseed rape, safflower, sunflower, Cal-
endula, Mortierella or Saccharomyces cerevisiae being especially preferred. In principle, host organisms are, in addition
to the abovementioned transgenic organisms, also transgenic animals, advantageously nonhuman animals, for example
C. elegans, Ciona intestinalis or Xenopus laevis.
[0058] Further utilizable host cells are detailed in: Goeddel, Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, CA (1990).
[0059] Expression strains which can be used, for example those with a lower protease activity, are described in:
Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California
(1990) 119-128.
[0060] These include plant cells and certain tissues, organs and parts of plants in all their phenotypic forms such as
anthers, fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested material, plant tissue, reproductive
tissue and cell cultures which are derived from the actual transgenic plant and/or can be used for bringing about the
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transgenic plant.
[0061] Transgenic plants which comprise the polyunsaturated fatty acids synthesized in the process according to the
invention can advantageously be marketed directly without there being any need for the oils, lipids or fatty acids syn-
thesized to be isolated. Plants for the process according to the invention are listed as meaning intact plants and all plant
parts, plant organs or plant parts such as leaf, stem, seeds, root, tubers, anthers, fibers, root hairs, stalks, embryos,
calli, cotelydons, petioles, harvested material, plant tissue, reproductive tissue and cell cultures which are derived from
the actual transgenic plant and/or can be used for bringing about the transgenic plant. In this context, the seed comprises
all parts of the seed such as the seed coats, epidermal cells, seed cells, endosperm or embryonic tissue. However, the
compounds produced in the process according to the invention can also be isolated from the organisms, advantageously
plants, in the form of their oils, fats, lipids and/or free fatty acids. Polyunsaturated fatty acids produced by this process
can be obtained by harvesting the organisms, either from the crop in which they grow, or from the field. This can be
done via pressing or extraction of the plant parts, preferably the plant seeds. In this context, the oils, fats, lipids and/or
free fatty acids can be obtained by what is known as cold-beating or cold-pressing without applying heat. To allow for
greater ease of disruption of the plant parts, specifically the seeds, they are previously comminuted, steamed or roasted.
The seeds which have been pretreated in this manner can subsequently be pressed or extracted with solvents such as
warm hexane. The solvent is subsequently removed. In the case of microorganisms, the latter are, after harvesting, for
example extracted directly without further processing steps or else, after disruption, extracted via various methods with
which the skilled worker is familiar. In this manner, more than 96% of the compounds produced in the process can be
isolated. Thereafter, the resulting products are processed further, i.e. refined. In this process, substances such as the
plant mucilages and suspended matter are first removed. What is known as desliming can be effected enzymatically or,
for example, chemico-physically by addition of acid such as phosphoric acid. Thereafter, the free fatty acids are removed
by treatment with a base, for example sodium hydroxide solution. The resulting product is washed thoroughly with water
to remove the alkali remaining in the product and then dried. To remove the pigment remaining in the product, the
products are subjected to bleaching, for example using filler’s earth or active charcoal. At the end, the product is deo-
dorized, for example using steam.
[0062] The fatty acids produced by the processes of the present invention can be isolated from the organism in the
form of an oil, a lipid or a free fatty acid. Suitable organisms are, for example, those mentioned above. Preferred organisms
are transgenic plants. One embodiment of the invention is therefore oils, lipids or fatty acids of formula I or fractions
thereof which have been produced by the above-described process, especially preferably oil, lipid or a fatty acid com-
position comprising a compound of formula I and being derived from transgenic plants.
[0063] As described above, these oils, lipids or fatty acids advantageously comprise 6 to 15% of palmitic acid, 1 to
6% of stearic acid, 7-85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1% of arachic acid, 7 to 25% of saturated fatty
acids, 8 to 85% of monounsaturated fatty acids and 60 to 85% of polyunsaturated fatty acids, in each case based on
100% and on the total fatty acid content of the organisms. Advantageous polyunsaturated fatty acids which are present
in the fatty acid esters or fatty acid mixtures are preferably at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1% of
arachidonic acid, based on the total fatty acid content. Moreover, the fatty acid esters or fatty acid mixtures which have
been produced by the process of the invention advantageously comprise fatty acids selected from the group of the fatty
acids erucic acid (13-docosaenoic acid), sterculic acid (9,1 0-methyleneoctadec-9-enoic acid), malvalic acid (8,9-meth-
yleneheptadec-8-enoic acid), chaulmoogric acid (cyclo-pentenedodecanoic acid), furan fatty acid (9,12-epoxyoctadeca-
9,11-dienoic acid), vernolic acid (9,10-epoxyoctadec-12-enoic acid), tariric acid (6-octadecynoic acid), 6-nonadecynoic
acid, santalbic acid (t11-octadecen-9-ynoic acid), 6,9-octadecenynoic acid, pyrulic acid (t10-heptadecen-8-ynoic acid),
crepenyninic acid (9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, octadecen-13-ene-9,11-diynoic acid, pet-
roselenic acid (cis-6-octadecenoic acid), 9c,12t-octadecadienoic acid, calendulic acid (8t10t12c-octadecatrienoic acid),
catalpic acid (9t11t13c-octadecatrienoic acid), eleostearic acid (9c11t13t-octadecatrienoic acid), jacaric acid (8c10t12c-
octadecatrienoic acid), punicic acid (9c11t13c-octadecatrienoic acid), parinaric acid (9c11t13t15c-octadecatetraenoic
acid), pinolenic acid (all-cis-5,9,12-octadecatrienoic acid), laballenic acid (5,6-octadecadienallenic acid), ricinoleic acid
(12-hydroxyoleic acid) and/or coriolic acid (13-hydroxy-9c, 11 t-octadecadienoic acid). The abovementioned fatty acids
are, as a rule, advantageously only found in traces in the fatty acid esters or fatty acid mixtures produced by the process
according to the invention, that is to say that, based on the total fatty acids, they occur to less than 30%, preferably to
less than 25%, 24%, 23%, 22% or 21%, especially preferably to less than 20%, 15%, 10%, 9%, 8%, 7%, 6% or 5%,
very especially preferably to less than 4%, 3%, 2% or 1%. In a further preferred form of the invention, these abovemen-
tioned fatty acids occur to less than 0.9%, 0.8%, 0.7%, 0.6% or 0.5%, especially preferably to less than 0.4%, 0.3%,
0.2%, 0.1%, based on the total fatty acids. The fatty acid esters or fatty acid mixtures produced by the process according
to the invention advantageously comprise less than 0.1%, based on the total fatty acids, and/or no butyric acid, no
cholesterol, no clupanodonic acid (= docosapentaenoic acid, C22:5∆4,8,12,15,21) and no nisinic acid (tetracosahexaenoic
acid, C23:6∆3,8,12,15,18,21).
[0064] A further embodiment according to the invention is the use of the oil, lipid, the fatty acids and/or the fatty acid
composition in feedstuffs, foodstuffs, cosmetics or pharmaceuticals. The oils, lipids, fatty acids or fatty acid mixtures
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according to the invention can be used in the manner with which the skilled worker is familiar for mixing with other oils,
lipids, fatty acids or fatty acid mixtures of animal origin, such as, for example, fish oils. These oils, lipids, fatty acids or
fatty acid mixtures, which are composed of vegetable and animal constituents, may also be used for the preparation of
feedstuffs, foodstuffs, cosmetics or pharmacologicals.
[0065] The term "oil", "lipid" or "fat" is understood as meaning a fatty acid mixture comprising unsaturated, saturated,
preferably esterified, fatty acid(s). The oil, lipid or fat is preferably high in polyunsaturated free or, advantageously,
esterified fatty acid(s), in particular linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, α-linolenic
acid, stearidonic acid, eicosatetraenoic acid, eicosapentaenoic acid, docosapentaenoic acid or docosahexaenoic acid.
[0066] The amount of unsaturated esterified fatty acids preferably amounts to approximately 30%, a content of 50%
is more preferred, a content of 60%, 70%, 80% or more is even more preferred. For the analysis, the fatty acid content
can, for example, be determined by gas chromatography after converting the fatty acids into the methyl esters by
transesterification. The oil, lipid or fat can comprise various other saturated or unsaturated fatty acids, for example
calendulic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid and the like. The content of the various fatty acids
in the oil or fat can vary, in particular depending on the starting organism.
[0067] The ∆5-unsaturated fatty acids which are produced in the process are, as described above, for example sphin-
golipids, phosphoglycerides, lipids, glycolipids, phospholipids, monoacylglycerol, diacylglycerol, triacylglycerol or other
fatty acid esters.
[0068] Starting from the polyunsaturated fatty acids with advantageously at least five or six double bonds, which acids
have been prepared in the process according to the invention, the polyunsaturated fatty acids which are present can be
liberated for example via treatment with alkali, for example aqueous KOH or NaOH, or acid hydrolysis, advantageously
in the presence of an alcohol such as methanol or ethanol, or via enzymatic cleavage, and isolated via, for example,
phase separation and subsequent acidification via, for example, H2SO4. The fatty acids can also be liberated directly
without the above-described processing step.
[0069] After their introduction into an organism, advantageously a plant cell or plant, the nucleic acids used in the
process can either be present on a separate plasmid or, advantageously, integrated into the genome of the host cell. In
the case of integration into the genome, integration can be random or else be effected by recombination such that the
native gene is replaced by the copy introduced, whereby the production of the desired compound by the cell is modulated,
or by the use of a gene in trans, so that the gene is linked operably with a functional expression unit which comprises
at least one sequence which ensures the expression of a gene and at least one sequence which ensures the polyade-
nylation of a functionally transcribed gene. The nucleic acids are advantageously introduced into the organisms via
multiexpression cassettes or constructs for multiparallel expression, advantageously into the plants for the multiparallel
seed-specific expression of genes.
[0070] If microorganisms such as yeasts, such as Saccharomyces or Schizosaccharomyces, fungi such as Mortierella,
Aspergillus, Phytophtora, Entomophthora, Mucor or Thraustochytrium, algae such as Isochrysis, Mantoniella, Euglena,
Ostreococcus, Phaeodactylum or Crypthecodinium are used as organisms in the process according to the invention,
these organisms are advantageously grown in fermentation cultures.
[0071] If microorganisms are used as organisms in the process according to the invention, they are grown or cultured
in the manner with which the skilled worker is familiar, depending on the host organism. As a rule, microorganisms are
grown in a liquid medium comprising a carbon source, usually in the form of sugars, a nitrogen source, usually in the
form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as salts
of iron, manganese and magnesium and, if appropriate, vitamins, at temperatures of between 0°C and 100°C, preferably
between 10°C and 60°C, while passing in oxygen. The pH of the liquid medium can either be kept constant, that is to
say regulated during the culturing period, or not. The cultures can be grown batchwise, semi-batchwise or continuously.
Nutrients can be provided at the beginning of the fermentation or fed in semicontinuously or continuously. The polyun-
saturated fatty acids produced can be isolated from the organisms as described above by processes known to the skilled
worker, for example by extraction, distillation, crystallization, if appropriate precipitation with salt, and/or chromatography.
To this end, the organisms can advantageously be disrupted beforehand.
[0072] If the host organisms are microorganisms, the process according to the invention is advantageously carried
out at a temperature of between 0°C and 95°C, preferably between 10°C and 85°C, especially preferably between 15°C
and 75°C, very especially preferably between 15°C and 45°C.
[0073] In this process, the pH value is advantageously kept between pH 4 and 12, preferably between pH 6 and 9,
especially preferably between pH 7 and 8.
[0074] The process according to the invention can be operated batchwise, semibatchwise or continuously. An overview
over known cultivation methods can be found in the textbook by Chmiel (Bioprozeßtechnik 1. Einführung in die Biover-
fahrenstechnik [Bioprocess technology 1. Introduction to Bioprocess technology] (Gustav Fischer Verlag, Stuttgart,
1991)) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen [Bioreactors and peripheral equipment]
(Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
[0075] The culture medium to be used must suitably meet the requirements of the strains in question. Descriptions of
EP 2 388 332 A1
16
5
10
15
20
25
30
35
40
45
50
55
culture media for various microorganisms can be found in the textbook "Manual of Methods für General Bacteriology"
of the American Society for Bacteriology (Washington D. C., USA, 1981).
[0076] As described above, these media which can be employed in accordance with the invention usually comprise
one or more carbon sources, nitrogen sources, inorganic salts, vitamins and/or trace elements.
[0077] Preferred carbon sources are sugars, such as mono-, di- or polysaccharides. Examples of very good carbon
sources are glucose, fructose, mannose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch
or cellulose. Sugars can also be added to the media via complex compounds such as molasses or other byproducts
from sugar raffination. The addition of mixtures of a variety of carbon sources may also be advantageous. Other possible
carbon sources are oils and fats such as, for example, soya oil, sunflower oil, peanut oil and/or coconut fat, fatty acids
such as, for example, palmitic acid, stearic acid and/or linoleic acid, alcohols and/or polyalcohols such as, for example,
glycerol, methanol and/or ethanol, and/or organic acids such as, for example, acetic acid and/or lactic acid.
[0078] Nitrogen sources are usually organic or inorganic nitrogen compounds or materials comprising these com-
pounds. Examples of nitrogen sources comprise ammonia in liquid or gaseous form or ammonium salts such as am-
monium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea,
amino acids or complex nitrogen sources such as cornsteep liquor, soya meal, soya protein, yeast extract, meat extract
and others. The nitrogen sources can be used individually or as a mixture.
[0079] Inorganic salt compounds which may be present in the media comprise the chloride, phosphorus and sulfate
salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron.
[0080] Inorganic sulfur-containing compounds such as, for example, sulfates, sulfites, dithionites, tetrathionates, thi-
osulfates, sulfides, or else organic sulfur compounds such as mercaptans and thiols may be used as sources of sulfur
for the production of sulfur-containing fine chemicals, in particular of methionine.
[0081] Phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding
sodium-containing salts may be used as sources of phosphorus. Chelating agents may be added to the medium in order
to keep the metal ions in solution. Particularly suitable chelating agents include dihydroxyphenols such as catechol or
protocatechuate and organic acids such as citric acid.
[0082] The fermentation media used according to the invention for culturing microorganisms usually also comprise
other growth factors such as vitamins or growth promoters, which include, for example, biotin, riboflavin, thiamine, folic
acid, nicotinic acid, panthothenate and pyridoxine. Growth factors and salts are frequently derived from complex media
components such as yeast extract, molasses, cornsteep liquor and the like. It is moreover possible to add suitable
precursors to the culture medium. The exact composition of the media compounds heavily depends on the particular
experiment and is decided upon individually for each specific case. Information on the optimization of media can be
found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Editors P.M. Rhodes, P.F. Stanbury, IRL
Press (1997) pp. 53-73, ISBN 0 19 963577 3). Growth media can also be obtained from commercial suppliers, for
example Standard 1 (Merck) or BHI (brain heart infusion, DIFCO) and the like.
[0083] All media components are sterilized, either by heat (20 min at 1.5 bar and 121°C) or by filter sterilization. The
components may be sterilized either together or, if required, separately. All media components may be present at the
start of the cultivation or added continuously or batchwise, as desired.
[0084] The culture temperature is normally between 15°C and 45°C, preferably at from 25°C to 40°C, and may be
kept constant or may be altered during the experiment. The pH of the medium should be in the range from 5 to 8.5,
preferably around 7.0. The pH for cultivation can be controlled during cultivation by adding basic compounds such as
sodium hydroxide, potassium hydroxide, ammonia and aqueous ammonia or acidic compounds such as phosphoric
acid or sulfuric acid. Foaming can be controlled by employing antifoams such as, for example, fatty acid polyglycol
esters. To maintain the stability of plasmids it is possible to add to the medium suitable substances having a selective
effect, for example antibiotics. Aerobic conditions are maintained by introducing oxygen or oxygen-containing gas mix-
tures such as, for example, ambient air into the culture. The temperature of the culture is normally 20° to 40°C and
preferably 25°C to 40°C. The culture is continued until formation of the desired product is at a maximum. This aim is
normally achieved within 10 to 160 hours.
[0085] The fermentation broths obtained in this way, in particular those containing polyunsaturated fatty acids, usually
contain a dry mass of from 7.5 to 25% by weight. The fermentation broth can then be processed further. The biomass
may, according to requirement, be removed completely or partially from the fermentation broth by separation methods
such as, for example, centrifugation, filtration, decanting or a combination of these methods or be left completely in said
broth. It is advantageous to process the biomass after its separation.
[0086] However, the fermentation broth can also be thickened or concentrated without separating the cells, using
known methods such as, for example, with the aid of a rotary evaporator, thin-film evaporator, falling-film evaporator,
by reverse osmosis or by nanofiltration. Finally, this concentrated fermentation broth can be processed to obtain the
fatty acids present therein.
[0087] The fatty acids obtained in the process are also suitable as starting material for the chemical synthesis of further
products of interest. For example, they can be used in combination with one another or alone for the preparation of
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pharmaceuticals, foodstuffs, animal feeds or cosmetics.
[0088] All of the nucleic acid sequences used in the process according to the invention are advantageously derived
from a eukaryotic organism such as a plant, a microorganism or an animal. The nucleic acid sequences are preferably
derived from the order Salmoniformes, algae such as Mantoniella, Crypthecodinium, Euglena or Ostreococcus, fungi
such as the genus Phytophthora or from diatoms such as the genera Thalassiosira or Phaeodactylum.
[0089] The invention furthermore relates to isolated nucleic acid sequences encoding polypeptides with ∆5-desaturase
activity.
[0090] Therefore, in a further aspect of the invention there is provided an isolated nucleic acid sequence which encodes
a polypeptide with ∆5-desaturase activity and which is selected from the group consisting of:
a) SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5;
b) nucleic acid sequences which hybridize under stringent conditions with a nucleic acid sequence of SEQ ID NO:
1, SEQ ID NO: 3 or SEQ ID NO: 5.
c) an isolated nucleic acid sequence which encodes a polypeptide with ∆5-desaturase activity, wherein the polypep-
tide is selected from the group consisting of SEQ ID NO:2, SEQ ID NO: 4 or SEQ ID NO: 6;
d) A derivative of a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ I D NO: 5 which encodes a
polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6,
wherein said polypeptide has ∆5-desaturase activity.
[0091] In still another aspect of the invention there is provided an amino acid sequence which is encoded by a nucleic
acid sequence in (a), (b), (c) or (d) above.
[0092] Advantageously, the proteins encoded by these nucleic acid molecules have at least approximately 50%,
preferably at least approximately 60% and more preferably at least approximately 70%, 80% or 90% and most preferably
at least approximately 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more
identity with the amino acid sequences shown in SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6.
[0093] The nucleic acid sequences used in the process are advantageously introduced into an expression cassette
which makes possible the expression of the nucleic acids in organisms such as microorganisms or plants.
[0094] Therefore, in another aspect of the invention there is provided a gene construct comprising a nucleic acid
sequence which encodes a polypeptide with ∆5-desaturase activity as set out above, operably linked with one or more
regulatory sequences.
[0095] In the expression cassette, the nucleic acid sequence which encode ∆5-desaturase, is linked operably with
one or more regulatory sequences, advantageously for enhancing gene expression. These regulatory sequences are
intended to make possible the specific expression of the genes and proteins. Depending on the host organism, this may
mean, for example, that the gene is expressed and/or overexpressed only after induction has taken place, or else that
it is expressed and/or overexpressed immediately. For example, these regulatory sequences take the form of sequences
to which inductors or repressors bind, thus controlling the expression of the nucleic acid. In addition to these novel
regulatory sequences, or instead of these sequences, the natural regulatory elements of these sequences may still be
present before the actual structural genes and, if appropriate, may have been genetically modified in such a way that
their natural regulation is eliminated and the expression of the genes is enhanced. However, the expression cassette
(= expression construct = gene construct) can also be simpler in construction, that is to say no additional regulatory
signals have been inserted before the nucleic acid sequence or its derivatives, and the natural promoter together with
its regulation was not removed. Instead, the natural regulatory sequence has been mutated in such a way that regulation
no longer takes place and/or gene expression is enhanced. These modified promoters can also be positioned on their
own before the natural gene in the form of part-sequences (= promotor with parts of the nucleic acid sequences used
in accordance with the invention) in order to enhance the activity. Moreover, the gene construct may advantageously
also comprise one or more what are known as enhancer sequences in operable linkage with the promoter, which make
possible an enhanced expression of the nucleic acid sequence. Additional advantageous sequences, such as further
regulatory elements or terminator sequences, may also be inserted at the 3’ end of the DNA sequences. The ∆12-
desaturase, ω3-desaturase, ∆4-desaturase, ∆5-desaturase, ∆6-desaturase, ∆8-desaturase, ∆5-elongase, ∆6-elongase
and/or ∆9-elongase genes may be present in one or more copies of the expression cassette (= gene construct). Preferably,
only one copy of the genes is present in each expression cassette. This gene construct or the gene constructs can be
expressed together in the host organism. In this context, the gene construct(s) can be inserted in one or more vectors
and be present in the cell in free form, or else be inserted in the genome. It is advantageous for the insertion of further
genes in the genome when the genes to be expressed are present together in one gene construct.
[0096] In this context, the regulatory sequences or factors can, as described above, preferably have a positive effect
on the gene expression of the genes introduced, thus enhancing it. Thus, an enhancement of the regulatory elements,
advantageously at the transcriptional level, may take place by using strong transcription signals such as promoters
and/or enhancers. In addition, however, enhanced translation is also possible, for example by improving the stability of
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the mRNA.
[0097] The regulatory sequences include, in particular, plant sequences such as promoter and terminator sequences.
The constructs can advantageously be stably propagated in microorganisms, in particular in E. coli and Agrobacterium
tumefaciens, under selective conditions and make possible the transfer of heterologous DNA into plants or microorgan-
isms.
[0098] Useful regulatory sequences are present, for example, in promoters such as the cos, tac, trp, tet, trp-tet, lpp,
lac, lpp-lac, laclq, T7, T5, T3, gal, trc, ara, SP6, λ-PR or λ-PL promoter and are advantageously employed in Gram-
negative bacteria. Further advantageous regulatory sequences are, for example, present in the Gram-positive promoters
amy and SPO2, in the yeast or fungal promoters ADC1, MFα, AC, P-60, CYC1, GAPDH, TEF, rp28, ADH or in the plant
promoters CaMV/35S [Franck et al., Cell 21 (1980) 285-294], PRP1 [Ward et al., Plant. Mol. Biol. 22 (1993)], SSU, OCS,
lib4, usp, STLS1, B33, nos or in the ubiquitin or phaseolin promoter. Advantageous in this context are also inducible
promoters, such as the promoters described in EP-A-0 388 186 (benzenesulfonamide-inducible), Plant J. 2, 1992:
397-404 (Gatz et al., tetracycline-inducible), EP-A-0 335 528 (abscissic acid-inducible) or WO 93/21334 (ethanol- or
cyclohexenol-inducible) promoters. Further suitable plant promoters are the cytosolic FBPase promoter or the ST-LSI
promoter of potato (Stockhaus et al., EMBO J. 8, 1989, 2445), the glycine max phosphoribosylpyrophosphate ami-
dotransferase promoter (Genbank Accession No.. U87999) or the node-specific promoter described in EP-A-0 249 676.
[0099] Especially advantageous promoters are promoters which make possible the expression in tissues which are
involved in the biosynthesis of fatty acids. Very especially advantageous are seed-specific promoters, such as the USP
promoter as described, but also other promoters such as the LeB4, DC3, phaseolin or napin promoter. Further especially
advantageous promoters are seed-specific promoters which can be used for monocotyledonous or dicotyledonous plants
and which are described in US 5,608,152 (oilseed rape napin promoter), WO 98/45461 (Arabidopsis oleosin promoter),
[0100] US 5,504,200 (Phaseolus vulgaris phaseolin promoter), WO 91/13980 (Brassica Bce4 promoter), by Baeumlein
et al., Plant J., 2, 2, 1992:233-239 (LeB4 promoter from a legume), these promoters being suitable for dicots. Examples
of promoters which are suitable for monocots are the barley Ipt-2 or Ipt-1 promoter (WO 95/15389 and WO 95/23230),
the barley hordein promoter and other suitable promoters described in WO 99/16890.
[0101] In principle, it is possible to use all natural promoters together with their regulatory sequences, such as those
mentioned above. It is also possible and advantageous to use synthetic promoters, either in addition or alone, in particular
when they mediate seed-specific expression, such as those described in WO 99/16890.
[0102] In order to achieve a particularly high ∆5-unsaturated fatty acid content, especially in transgenic plants, the ∆5-
desaturase genes should advantageously be expressed in oil crops in a seed-specific manner. To this end, seed-specific
promoters can be used, or those promoters which are active in the embryo and/or in the endosperm. In principle, seed-
specific promoters can be isolated both from dicotyledonous and from monocotyledonous plants. Preferred promoters
are listed hereinbelow: USP (= unknown seed protein) and vicilin (Vicia faba) [Bäumlein et al., Mol. Gen Genet., 1991,
225(3)], napin (oilseed rape) [US 5,608,152], acyl carrier protein (oilseed rape) [US 5,315,001 and WO 92/18634], oleosin
(Arabidopsis thaliana) [WO 98/45461 and WO 93/20216], phaseolin (Phaseolus vulgaris) [US 5,504,200], Bce4 [WO
91/13980], legumines B4 (LegB4 promoter) [Bäumlein et al., Plant J., 2,2, 1992], Lpt2 and Ipt1 (barley) [WO 95/15389
and WO95/23230], seed-specific promoters from rice, maize and wheat [WO 99/16890], Amy32b, Amy 6-6 and aleurain
[US 5,677,474], Bce4 (oilseed rape) [US 5,530,149], glycinin (soybean) [EP 571 741], phosphoenol pyruvate carboxylase
(soybean) [JP 06/62870], ADR12-2 (soybean) [WO 98/08962], isocitrate lyase (oilseed rape) [US 5,689,040] or α-
amylase (barley) [EP 781 849].
[0103] Plant gene expression can also be facilitated via a chemically inducible promoter (see review in Gatz 1997,
Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are particularly suitable when it
is desired that gene expression should take place in a time-specific manner. Examples of such promoters are a salicylic-
acid-inducible promoter (WO 95/19443), a tetracycline-inducible promoter (Gatz et al. (1992) Plant J. 2, 397-404) and
an ethanol-inducible promoter.
[0104] To ensure the stable integration of the biosynthesis genes into the transgenic plant over a plurality of generations,
each of the nucleic acids which encode ∆2-desaturase, ω3-desaturase, ∆9-elongase, ∆6-desaturase, ∆8-desaturase,
∆6-elongase, ∆5-desaturase, ∆5-elongase and/or ∆4-desaturase and which are used in the process should be expressed
under the control of a separate promoter, preferably a promoter which differs from the other promoters, since repeating
sequence motifs can lead to instability of the T-DNA, or to recombination events. In this context, the expression cassette
is advantageously constructed in such a way that a promoter is followed by a suitable cleavage site, advantageously in
a polylinker, for insertion of the nucleic acid to be expressed and, if appropriate, a terminator sequence is positioned
behind the polylinker. This sequence is repeated several times, preferably three, four or five times, so that up to five
genes can be combined in one construct and introduced into the transgenic plant in order to be expressed. Advanta-
geously, the sequence is repeated up to three times. To express the nucleic acid sequences, the latter are inserted
behind the promoter via a suitable cleavage site, for example in the polylinker. Advantageously, each nucleic acid
sequence has its own promoter and, if appropriate, its own terminator sequence. Such advantageous constructs are
disclosed, for example, in DE 101 02 337 or DE 101 02 338. However, it is also possible to insert a plurality of nucleic
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acid sequences behind a promoter and, if appropriate, before a terminator sequence. Here, the insertion site, or the
sequence, of the inserted nucleic acids in the expression cassette is not of critical importance, that is to say a nucleic
acid sequence can be inserted at the first or last position in the cassette without its expression being substantially
influenced thereby. Advantageously, different promoters such as, for example, the USP, LegB4 or DC3 promoter, and
different terminator sequences can be used in the expression cassette. However, it is also possible to use only one type
of promoter in the cassette. This, however, may lead to undesired recombination events.
[0105] As described above, the transcription of the genes which have been introduced should advantageously be
terminated by suitable terminator sequences at the 3’ end of the biosynthesis genes which have been introduced (behind
the stop codon). An example of a sequence which can be used in this context is the OCS 1 terminator sequence. As is
the case with the promoters, different terminator sequences should be used for each gene.
[0106] Advantageously, in particular for the process of the second aspect of the invention, the gene construct addi-
tionally comprises a nucleic acid sequence encoding a polypeptide having ∆9-elongase activity, for example a sequence
encoding the C18-∆9 elongase from Isochrysis galbana (SEQ ID NO: 25)or Acanthamoeba castellanii (SEQ ID NO: 24)
[0107] The gene construct of the present invention may also comprise biosynthesis genes of the fatty acid or lipid
metabolism selected from the group acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein] desaturase(s), acyl-
ACP thioesterase(s),fatty acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s),
fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acylcoenzyme A oxidase(s), fatty acid desaturase(s), fatty
acid acetylenases, lipoxygenases, triacylglycerol lipases, allenoxide synthases, hydroperoxide lyases or fatty acid elon-
gase(s) and desaturase(s) such as ∆4-desaturase, ∆5-desaturase, ∆6-desaturase, ∆8-desaturase, ∆9-desaturase, ∆12-
desaturase or ∆6-elongase.
[0108] These additional nucleic acids or genes can be cloned into the expression cassettes, which are then used for
transforming plants with the aid of vectors such as Agrobacterium.
[0109] Here, the regulatory sequences or factors can, as described above, preferably have a positive effect on, and
thus enhance, the expression genes which have been introduced. Thus, enhancement of the regulatory elements can
advantageously take place at the transcriptional level by using strong transcription signals such as promoters and/or
enhancers. However, an enhanced translation is also possible, for example by improving the stability of the mRNA. In
principle, the expression cassettes can be used directly for introduction into the plants or else be introduced into a vector.
Therefore, in yet another aspect of the invention, there is provided a vector comprising a nucleic acid or a gene construct
in any of the aspects of the invention described above.
[0110] In one embodiment, the vector may be a cloning vector.
[0111] The nucleic acid sequences of the invention may be introduced alone, or preferably, in combination with an
expression cassette (nucleic acid construct) into an organism. To introduce the nucleic acids, the latter are advantageously
amplified and ligated in the known manner. Preferably, a procedure following the protocol for Pfu DNA polymerase or
a Pfu/Taq DNA polymerase mixture is followed. The primers are selected taking into consideration the sequence to be
amplified. The primers should advantageously be chosen in such a way that the amplificate comprises the entire co-
dogenic sequence from the start codon to the stop codon. After the amplification, the amplificate is expediently analyzed.
For example, a gel-electrophoretic separation can be carried out, which is followed by a quantitative and a qualitative
analysis. Thereafter, the amplificate can be purified following a standard protocol (for example Qiagen). An aliquot of
the purified amplificate is then available for the subsequent cloning step. Suitable cloning vectors are generally known
to the skilled worker. These include, in particular, vectors which are capable of replication in microbial systems, that is
to say mainly vectors which ensure efficient cloning in yeasts or fungi and which make possible the stable transformation
of plants. Those which must be mentioned in particular are various binary and cointegrated vector systems which are
suitable for the T-DNA-mediated transformation. Such vector systems are, as a rule, characterized in that they comprise
at least the vir genes required for the Agrobacterium-mediated transformation and the T-DNA-delimiting sequences (T-
DNA border). These vector systems advantageously also comprise further cis-regulatory regions such as promoters
and terminator sequences and/or selection markers, by means of which suitably transformed organisms can be identified.
While in the case of cointegrated vector systems vir genes and T-DNA sequences are arranged on the same vector,
binary systems are based on at least two vectors, one of which bears vir genes, but no T-DNA, while a second one
bears T-DNA, but no vir gene. Owing to this fact, the last-mentioned vectors are relatively small, easy to manipulate and
to replicate both in E. coli and in Agrobacterium. These binary vectors include vectors from the series pBIB-HYG, pPZP,
pBecks, pGreen. In accordance with the invention, Bin19, pBI101, pBinAR, pGPTV and pCAMBIA are used by preference.
An overview of the binary vectors and their use is found in Hellens et al, Trends in Plant Science (2000) 5, 446-451. In
order to prepare the vectors, the vectors can first be linearized with restriction endonuclease(s) and then modified
enzymatically in a suitable manner. Thereafter, the vector is purified, and an aliquot is employed for the cloning step. In
the cloning step, the enzymatically cleaved and, if appropriate, purified amplificate is cloned with vector fragments which
have been prepared in a similar manner, using ligase. In this context, a particular nucleic acid construct, or vector or
plasmid construct, can have one or else more than one codogenic gene segment. The codogenic gene segments in
these constructs are preferably linked operably with regulatory sequences. The regulatory sequences include, in par-
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ticular, plant sequences such as the above-described promoters and terminator sequences. The constructs can advan-
tageously be stably propagated in microorganisms, in particular in E. coli and Agrobacterium tumefaciens, under selective
conditions and make possible the transfer of heterologous DNA into plants or microorganisms.
[0112] The nucleic acids used in the process, the inventive nucleic acids and nucleic acid constructs, can be introduced
into organisms such as microorganisms or advantageously plants, advantageously using cloning vectors, and thus be
used in the transformation of plants such as those which are published and cited in: Plant Molecular Biology and Bio-
technology (CRC Press, Boca Raton, Florida), Chapter 6/7, p. 71-119 (1993); F.F. White, Vectors for Gene Transfer in
Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu, Academic Press, 1993,
15-38; B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.:
Kung and R. Wu, Academic Press (1993), 128-143; Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991),
205-225. Thus, the nucleic acids, the inventive nucleic acids and nucleic acid constructs, and/or vectors used in the
process can be used for the recombinant modification of a broad spectrum of organisms, advantageously plants, so that
the latter become better and/or more efficient producers of ∆5-unsaturated fatty acids.
[0113] A series of mechanisms exist by which a modification of the ∆5-desaturase protein is possible, so that the yield,
production and/or production efficiency of the advantageous ∆5-unsaturated fatty acids in a plant, preferably in an oil
crop plant or a microorganism, can be influenced directly owing to this modified protein. The number or activity of the
proteins or genes can be increased, so that greater amounts of the gene products and, ultimately, greater amounts of
the compounds of the general formula I are produced. A de novo synthesis in an organism which has lacked the activity
and ability to biosynthesize the compounds prior to introduction of the corresponding gene(s) is also possible. This
applies analogously to the combination with further desaturases or elongases or further enzymes of the fatty acid and
lipid metabolism. The use of various divergent sequences, i.e. sequences which differ at the DNA sequence level, may
also be advantageous in this context, or else the use of promoters for gene expression which make possible a different
gene expression in the course of time, for example as a function of the degree of maturity of a seed or an oil-storing tissue.
[0114] Owing to the introduction of a ∆5-desaturase gene into an organism, alone or in combination with other genes
in a cell, it is not only possible to increase biosynthesis flux towards the end product, but also to increase, or to create
de novo the corresponding triacylglycerol composition. Likewise, the number or activity of other genes which are involved
in the import of nutrients which are required for the biosynthesis of one or more fatty acids, oils, polar and/or neutral
lipids, can be increased, so that the concentration of these precursors, cofactors or intermediates within the cells or
within the storage compartment is increased, whereby the ability of the cells to produce ∆5-unsaturated fatty acids as
described below is enhanced further. By optimizing the activity or increasing the number of one or more ∆5-desaturase
genes which are involved in the biosynthesis of these compounds, or by destroying the activity of one or more genes
which are involved in the degradation of these compounds, an enhanced yield, production and/or efficiency of production
of fatty acid and lipid molecules in organisms, advantageously in plants, is made possible.
[0115] Nucleic acids which can advantageously be used in the process are derived from bacteria, fungi, diatoms,
animals such as Caenorhabditis or Oncorhynchus or plants such as algae or mosses, such as the genera Shewanella,
Physcomitrella, Thraustochytrium, Fusarium, Phytophthora, Ceratodon, Mantoniella, Ostreococcus, Isochrysis, Aleurita,
Muscarioides, Mortierella, Borago, Phaeodactylum, Crypthecodinium, specifically from the genera and species Onco-
rhynchus mykiss, Xenopus laevis, Ciona intestinalis, Thalassiosira pseudonona, Mantoniella squamata, Ostreococcus
sp., Ostreococcus tauri, Euglena gracilis, Physcomitrella patens, Phytophtora infestans, Fusarium graminaeum, Cryp-
tocodinium cohnii, Ceratodon purpureus, Isochrysis galbana, Acanthamoeba castellanii, Aleurita farinosa, Thrausto-
chytrium sp., Muscarioides viallii, Mortierella alpina, Borago officinalis, Phaeodactylum tricornutum, Caenorhabditis el-
egans or especially advantageously from Oncorhynchus mykiss, Euglena gracilis, Thalassiosira pseudonona or Cryp-
thecodinium cohnii.
[0116] In an alternative embodiment, the vector may be an expression vector designed to transform an organism in
which the nucleic acid is to be expressed and the compound of formula I is synthesized.
[0117] These advantageous vectors, preferably expression vectors, comprise the nucleic acids which encode the ∆5-
desaturase and which is used in the process of the first or second aspects
[0118] As used in the present context, the term "vector" refers to a nucleic acid molecule which is capable of transporting
another nucleic acid to which it is bound. One type of vector is a "plasmid", a circular double-stranded DNA loop into
which additional DNA segments can be ligated. A further type of vector is a viral vector, it being possible for additional
DNA segments to be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell
into which they have been introduced (for example bacterial vectors with bacterial replication origin). Other vectors are
advantageously integrated into the genome of a host cell when they are introduced into the host cell, and thus replicate
together with the host genome. Moreover, certain vectors can govern the expression of genes with which they are in
operable linkage. These vectors are referred to in the present context as "expression vectors". Usually, expression
vectors which are suitable for DNA recombination techniques take the form of plasmids.
[0119] In the present description, where the term "plasmid" is used, it should be understood that plasmids can be
substituted for other types of expression vector, such as viral vectors, which exert similar functions. Furthermore, the
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term "vector" is also intended to comprise other vectors with which the skilled worker is familiar, such as phages, viruses
such as SV40, CMV, TMV, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
[0120] The recombinant expression vectors advantageously used in the process comprise the nucleic acids described
below or the above-described gene construct in a form which is suitable for expressing the nucleic acids used in a host
cell, which means that the recombinant expression vectors comprise one or more regulatory sequences, selected on
the basis of the host cells used for the expression, which regulatory sequence(s) is/are linked operably with the nucleic
acid sequence to be expressed. In a recombinant expression vector, "linked operably" means that the nucleotide se-
quence of interest is bound to the regulatory sequence(s) in such a way that the expression of the nucleotide sequence
is possible and they are bound to each other in such a way that both sequences carry out the predicted function which
is ascribed to the sequence (for example in an in-vitro transcription/translation system, or in a host cell if the vector is
introduced into the host cell). The term "regulatory sequence" is intended to comprise promoters, enhancers and other
expression control elements (for example polyadenylation signals). These regulatory sequences are described, for
example, in Goeddel: Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA
(1990), or see: Gruber and Crosby, in: Methods in Plant Molecular Biology and Biotechnolgy, CRC Press, Boca Raton,
Florida, Ed.: Glick and Thompson, Chapter 7, 89-108, including the references cited therein. Regulatory sequences
comprise those which govern the constitutive expression of a nucleotide sequence in many types of host cell and those
which govern the direct expression of the nucleotide sequence only in specific host cells under specific conditions. The
skilled worker knows that the design of the expression vector can depend on factors such as the choice of host cell to
be transformed, the desired expression level of the protein and the like. The recombinant expression vectors used can
be designed for the expression of ∆5-desaturase in prokaryotic or eukaryotic cells. This is advantageous since interme-
diate steps of the vector construction are frequently carried out in microorganisms for the sake of simplicity. For example,
the ∆5-desaturase gene can be expressed in bacterial cells, insect cells (using Baculovirus expression vectors), yeast
and other fungal cells (see Romanos, M.A., et al. (1992) "Foreign gene expression in yeast: a review", Yeast 8:423-488;
van den Hondel, C.A.M.J.J., et al. (1991) "Heterologous gene expression in filamentous fungi", in: More Gene Manipu-
lations in Fungi, J.W. Bennet & L.L. Lasure, Ed., pp. 396-428: Academic Press: San Diego; and van den Hondel,
C.A.M.J.J., & Punt, P.J. (1991) "Gene transfer systems and vector development for filamentous fungi, in: Applied Mo-
lecular Genetics of Fungi, Peberdy, J.F., et al., Ed., pp. 1-28, Cambridge University Press: Cambridge), algae (Falciatore
et al., 1999, Marine Biotechnology.1, 3:239-251), ciliates of the types: Holotrichia, Peritrichia, Spirotrichia, Suctoria,
Tetrahymena, Paramecium, Colpidium, Glaucoma, Platyophrya, Potomacus, Desaturaseudocohnilembus, Euplotes,
Engelmaniella and Stylonychia, in particular of the genus Stylonychia lemnae, using vectors in a transformation method
as described in WO 98/01572 and, preferably, in cells of multi-celled plants (see Schmidt, R. and Willmitzer, L.
(1988) "High efficiency Agrobacterium tumefaciens-mediated transformation of Arabidopsis thaliana leaf and cotyledon
explants" Plant Cell Rep.:583-586; Plant Molecular Biology and Biotechnology, C Press, Boca Raton, Florida, Chapter
6/7, pp.71-119 (1993); F.F. White, B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering
and Utilization, Ed.: Kung and R. Wu, Academic Press (1993), 128-43; Potrykus, Annu. Rev. Plant Physiol. Plant Molec.
Biol. 42 (1991), 205-225 (and references cited therein)). Suitable host cells are furthermore discussed in Goeddel, Gene
Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA (1990). As an alternative, the
recombinant expression vector can be transcribed and translated in vitro, for example using T7-promoter regulatory
sequences and T7-polymerase.
[0121] In most cases, the expression of proteins in prokaryotes involves the use of vectors comprising constitutive or
inducible promoters which govern the expression of fusion or nonfusion proteins. Typical fusion expression vectors are,
inter alia, pGEX (Pharmacia Biotech Inc; Smith, D.B., and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New England
Biolabs, Beverly, MA) und pRIT5 (Pharmacia, Piscataway, NJ), where glutathione S-transferase (GST), maltose-E
binding protein and protein A, respectively, is fused with the recombinant target protein.
[0122] Examples of suitable inducible nonfusion E. coli expression vectors are, inter alia, pTrc (Amann et al. (1988)
Gene 69:301-315) and pET 11 d (Studier et al., Gene Expression Technology: Methods in Enzymology 185, Academic
Press, San Diego, California (1990) 60-89). The target gene expression from the pTrc vector is based on the transcription
from a hybrid trp-lac fusion promoter by the host RNA polymerase. The target gene expression from the vector pET 11
d is based on the transcription of a T7-gn10-lac fusion promoter, which is mediated by a viral RNA polymerase (T7 gn1),
which is coexpressed. This viral polymerase is provided by the host strains BL21 (DE3) or HMS174 (DE3) from a resident
λ-prophage which harbors a T7 gn1 gene under the transcriptional control of the lacUV 5 promoter.
[0123] Other vectors which are suitable for prokaryotic organisms are known to the skilled worker, these vectors are,
for example in E. coli pLG338, pACYC184, the pBR series such as pBR322, the pUC series such as pUC18 or pUC19,
the M113mp series, pKC30, pRep4, pHS1, pHS2, pPLc236, pMBL24, pLG200, pUR290, pIN-III113-B1, λgt11 or pBdCI,
in Streptomyces pIJ101, pIJ364, pIJ702 or pIJ361, in Bacillus pUB110, pC194 or pBD214, in Corynebacterium pSA77
or pAJ667.
[0124] In a further embodiment, the expression vector is a yeast expression vector. Examples for vectors for expression
in the yeast S. cerevisiae comprise pYeDesaturasec1 (Baldari et al. (1987) Embo J. 6:229-234), pMFa (Kurjan and
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Herskowitz (1982) Cell 30:933-943), pJRY88 (Schultz et al. (1987) Gene 54:113-123) and pYES2 (Invitrogen Corporation,
San Diego, CA). Vectors and processes for the construction of vectors which are suitable for use in other fungi, such
as the filamentous fungi, comprise those which are described in detail in: van den Hondel, C.A.M.J.J., & Punt, P.J. (1991)
"Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of fungi, J.F.
Peberdy et al., Ed., pp. 1-28, Cambridge University Press: Cambridge, or in: More Gene Manipulations in Fungi [J.W.
Bennet & L.L. Lasure, Ed., pp. 396-428: Academic Press: San Diego]. Further suitable yeast vectors are, for example,
pAG-1, YEp6, YEp13 or pEMBLYe23.
[0125] As an alternative, ∆5-desaturase can be expressed in insect cells using Baculovirus vectors. Baculovirus
expression vectors which are available for the expression of proteins in cultured insect cells (for example Sf9 cells)
comprise the pAc series (Smith et al. (1983) Mol. Cell Biol.. 3:2156-2165) and the pVL series (Lucklow and Summers
(1989) Virology 170:31-39).
[0126] The abovementioned vectors are only a small overview over suitable vectors which are possible. Further
plasmids are known to the skilled worker and are described, for example, in: Cloning Vectors (Ed. Pouwels, P.H., et al.,
Elsevier, Amsterdam-New York-Oxford, 1985, ISBN 0 444 904018). For further suitable expression systems for prokary-
otic and eukaryotic cells, see the Chapters 16 and 17 in Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning:
A Laboratory Manual, 2. edition, Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY, 1989.
[0127] In a further embodiment of the process, the ∆5-desaturase can be expressed in single-celled plant cells (such
as algae), see Falciatore et al., 1999, Marine Biotechnology 1 (3):239-251 and references cited therein, and in plant
cells from higher plants (for example spermatophytes such as arable crops). Examples of plant expression vectors
comprise those which are described in detail in: Becker, D., Kemper, E., Schell, J., and Masterson, R. (1992) "New plant
binary vectors with selectable markers located proximal to the left border", Plant Mol. Biol. 20:1195-1197; and Bevan,
M.W. (1984) "Binary Agrobacterium vectors for plant transformation", Nucl. Acids Res. 12:8711-8721; Vectors for Gene
Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu, Academic
Press, 1993, p. 15-38.
[0128] A plant expression cassette preferably comprises regulatory sequences which are capable of governing the
expression of genes in plant cells and which are linked operably so that each sequence can fulfill its function, such as
transcriptional termination, for example polyadenylation signals. Preferred polyadenylation signals are those which are
derived from Agrobacterium tumefaciens T-DNA, such as gene 3 of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3
(1984) 835 et seq.), which is known as octopine synthase, or functional equivalents thereof, but all other terminator
sequences which are functionally active in plants are also suitable.
[0129] Since plant gene expression is very often not limited to the transcriptional level, a plant expression cassette
preferably comprises other sequences which are linked operably, such as translation enhancers, for example the over-
drive sequence, which enhances the tobacco mosaic virus 5’ - untranslated leader sequence, which increases the
protein/RNA ratio (Gallie et al., 1987, Nucl. Acids Research 15:8693-8711).
[0130] As described above, plant gene expression must be linked operably with a suitable promoter which triggers
gene expression with the correct timing or in a cell- or tissue-specific manner. Utilizable promoters are constitutive
promoters (Benfey et al., EMBO J. 8 (1989) 2195-2202), such as those which are derived from plant viruses, such as
35S CaMV (Franck et al., Cell 21 (1980) 285-294), 19S CaMV (see also US 5352605 and WO 84/02913), or plant
promoters, such as the promoter of the Rubisco subunit, which is described in US 4,962,028.
[0131] Other preferred sequences for use in operable linkage in plant gene expression cassettes are targeting se-
quences, which are required for steering the gene product into its corresponding cell compartment (see a review in
Kermode, Crit. Rev. Plant Sci. 15, 4 (1996) 285-423 and references cited therein), for example into the vacuole, into the
nucleus, all types of plastids, such as amyloplasts, chloroplasts, chromoplasts, the extracellular space, the mitochondria,
the endoplasmid reticulum, elaioplasts, peroxisomes and other compartments of plant cells.
[0132] As described above, plant gene expression can also be achieved via a chemically inducible promoter (see
review in Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are partic-
ularly suitable when it is desired that the gene expression takes place in a time-specific manner. Examples of such
promoters are a salicylic-acid-inducible promoter (WO 95/19443), a tetracyclin-inducible promoter (Gatz et al. (1992)
Plant J. 2, 397-404) and an ethanol-inducible promoter.
[0133] Promoters which respond to biotic or abiotic stress conditions are also suitable, for example the pathogen-
induced PRP1 gene promoter (Ward et al., Plant. Mol. Biol. 22 (1993) 361-366), the heat-inducible tomato hsp80 promoter
(US 5,187,267), the chill-inducible potato alpha-amylase promoter (WO 96/12814) or the wound-inducible pinll promoter
(EP-A-0 375 091).
[0134] Especially preferred are those promoters which bring about the gene expression in tissues and organs in which
the biosynthesis of fatty acids, lipids and oils takes place, in seed cells, such as cells of the endosperm and of the
developing embryo. Suitable promoters are the oilseed rape napin promoter (US 5,608,152), the Vicia faba USP promoter
(Baeumlein et al., Mol Gen Genet, 1991, 225 (3):459-67), the Arabidopsis oleosin promoter (WO 98/45461), the Phaseolus
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vulgaris phaseolin promoter (US 5,504,200), the Brassica Bce4 promoter (WO 91/13980) or the legumine B4 promoter
(LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):233-9), and promoters which bring about the seed-specific expression
in monocotyledonous plants such as maize, barley, wheat, rye, rice and the like. Suitable noteworthy promoters are the
barley Ipt2 or Ipt1 gene promoter (WO 95/15389 and WO 95/23230) or the promoters from the barley hordein gene, the
rice glutelin gene, the rice oryzin gene, the rice prolamine gene, the wheat gliadine gene, the wheat glutelin gene, the
maize zeine gene, the oat glutelin gene, the sorghum kasirin gene or the rye secalin gene, which are described in WO
99/16890.
[0135] For the process of the second aspect, it may be desired to bring about the multiparallel expression of the ∆5-
desaturase and the ∆9-elongase used in the process. Such expression cassettes can be introduced via the simultaneous
transformation of a plurality of individual expression constructs or, preferably, by combining a plurality of expression
cassettes on one construct. Also, a plurality of vectors can be transformed with in each case a plurality of expression
cassettes and then transferred into the host cell.
[0136] Other promoters which are likewise especially suitable are those which bring about a plastid-specific expression,
since plastids constitute the compartment in which the precursors and some end products of lipid biosynthesis are
synthesized. Suitable promoters, such as the viral RNA polymerase promoter, are described in WO 95/16783 and WO
97/06250, and the cIpP promoter from Arabidopsis, described in WO 99/46394.
[0137] Vector DNA can be introduced into prokaryotic and eukaryotic cells via conventional transformation or trans-
fection techniques. The terms "transformation" and "transfection", conjugation and transduction, as used in the present
context, are intended to comprise a multiplicity of methods known in the prior art for the introduction of foreign nucleic
acid (for example DNA) into a host cell, including calcium phosphate or calcium chloride coprecipitation, DEAE-dextran-
mediated transfection, lipofection, natural competence, chemically mediated transfer, electroporation or particle bom-
bardment. Suitable methods for the transformation or transfection of host cells, including plant cells, can be found in
Sambrook et al. (Molecular Cloning: A Laboratory Manual., 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, 1989) and other laboratory textbooks such as Methods in Molecular Biology,
1995, Vol. 44, Agrobacterium protocols, Ed.: Gartland and Davey, Humana Press, Totowa, New Jersey.
[0138] In a further aspect of the invention there is provided a transgenic non human organism comprising at least one
nucleic acid, gene construct or vector according to a previous aspect of the invention.
[0139] The transgenic nonhuman organism may be a microorganism, a nonhuman animal or a plant.
[0140] Host cells which are suitable in principle for taking up the nucleic acid according to the invention, the gene
product according to the invention or the vector according to the invention are all prokaryotic or eukaryotic organisms.
The host organisms which are advantageously used are microorganisms such as fungi or yeasts, or plant cells, preferably
plants or parts thereof. Fungi, yeasts or plants are preferably used, especially plants, for example plants such as oil
crops, which are high in lipid compounds, such as oilseed rape, evening primrose, hemp, thistle, peanut, canola, linseed,
soybean, safflower, sunflower, borage, or plants such as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava,
pepper, Tagetes, Solanacea plants such as potato, tobacco, eggplant and tomato, Vicia species, pea, alfalfa, bushy
plants (coffee, cacao, tea), Salix species, trees (oil palm, coconut), and perennial grasses and fodder crops. Especially
preferred plants according to the invention are oil crops such as soybean, peanut, oilseed rape, canola, linseed, hemp,
evening primrose, sunflower, safflower, trees (oil palm, coconut).
[0141] In an advantageous embodiment, the term "nucleic acid (molecule)" as used in the present context additionally
comprises the untranslated sequence at the 3’ and at the 5’ end of the coding gene region: at least 500, preferably 200,
especially preferably 100 nucleotides of the sequence upstream of the 5’ end of the coding region and at least 100,
preferably 50, especially preferably 20 nucleotides of the sequence downstream of the 3’ end of the coding gene region.
An "isolated" nucleic acid molecule is separate from other nucleic acid molecules which are present in the natural source
of the nucleic acid. An "isolated" nucleic acid preferably has no sequences which naturally flank the nucleic acid in the
genomic DNA of the organism from which the nucleic acid is derived (for example sequences which are located at the
5’ and 3’ ends of the nucleic acid ). In various embodiments, the isolated ∆12-desaturase, ω3-desaturase, ∆9-elongase,
∆6-desaturase, ∆8-desaturase, ∆6-elongase, ∆5-desaturase, ∆5-elongase or ∆4-desaturase molecule can comprise for
example fewer than approximately 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequences which naturally
flank the nucleic acid molecule in the genomic DNA of the cell from which the nucleic acid is derived.
[0142] The nucleic acid molecules of the present invention, for example a nucleic acid molecule with a nucleotide
sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 or of a part thereof can be isolated using molecular-biological
standard techniques and the sequence information provided herein. Also, for example a homologous sequence or
homologous, conserved sequence regions can be identified at the DNA or amino acid level with the aid of comparative
algorithms. They can be used as hybridization probe and standard hybridization techniques (such as, for example, those
described in Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring Harbor Laboratory, Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989) for isolating further nucleic acid sequences which can
be used in the process.
[0143] Moreover, a nucleic acid molecule comprising a complete sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ
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ID NO: 5 or a part thereof can be isolated by polymerase chain reaction, where oligonucleotide primers which are used
on the basis of this sequence or parts thereof (for example a nucleic acid molecule comprising the complete sequence
or part thereof can be isolated by polymerase chain reaction using oligonucleotide primers which have been generated
based on this same sequence). For example, mRNA can be isolated from cells (for example by means of the guanidinium
thiocyanate extraction method of Chirgwin et al. (1979) Biochemistry 18:5294-5299) and cDNA by means of reverse
transcriptase (for example Moloney MLV reverse transcriptase, available from Gibco/BRL, Bethesda, MD, or AMV
reverse transcriptase, available from Seikagaku America, Inc., St.Petersburg, FL).
[0144] Synthetic oligonucleotide primers for the amplification by means of polymerase chain reaction can be generated
based on one of the sequences shown in SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 or with the aid of the amino
acid sequences detailed in SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 6.
[0145] A nucleic acid according to the invention can be amplified by standard PCR amplification techniques using
cDNA or, alternatively, genomic DNA as template and suitable oligonucleotide primers. The nucleic acid amplified thus
can be cloned into a suitable vector and characterized by means of DNA sequence analysis. Oligonucleotides which
correspond to a desaturase nucleotide sequence can be generated by standard synthetic methods, for example using
an automatic DNA synthesizer.
[0146] The abovementioned nucleic acids and protein molecules with ∆5-desaturase activity are used in the process
according to the invention for the modulation of the production of ∆5-unsaturated fatty acids in transgenic organisms,
advantageously in plants, such as maize, wheat, rye, oats, triticale, rice, barley, soybean, peanut, cotton, Linum species
such as linseed or flax, Brassica species such as oilseed rape, canola and turnip rape, pepper, sunflower, borage,
evening primrose and Tagetes, Solanaceae plants such as potato, tobacco, eggplant and tomato, Vicia species, pea,
cassava, alfalfa, bushy plants (coffee, cacao, tea), Salix species, trees (oil palm, coconut) and perennial grasses and
fodder crops, either directly (for example when the overexpression or optimization of a fatty acid biosynthesis protein
has a direct effect on the yield, production and/or production efficiency of the fatty acid from modified organisms) and/or
can have an indirect effect which nevertheless leads to an enhanced yield, production and/or production efficiency of
the ∆5-unsaturated fatty acids or a reduction of undesired compounds (for example when the modulation of the metabolism
of lipids and fatty acids, cofactors and enzymes lead to modifications of the yield, production and/or production efficiency
or the composition of the desired compounds within the cells, which, in turn, can affect the production of one or more
fatty acids).
[0147] The combination of various precursor molecules and biosynthesis enzymes leads to the production of various
fatty acid molecules, which has a decisive effect on lipid composition, since ∆5-unsaturated fatty acids are not only
incorporated into triacylglycerol but also into membrane lipids.
[0148] Brassicaceae, Boraginaceae, Primulaceae, or Linaceae are particularly suitable for the production of PUFAs,
for example stearidonic acid, eicosapentaenoic acid and docosahexaenoic acid. Linseed (Linum usitatissimum) is es-
pecially advantageously suitable for the production of PUFAs with the nucleic acid sequences according to the invention,
advantageously, as described, in combination with further desaturases and elongases.
[0149] Lipid synthesis can be divided into two sections: the synthesis of fatty acids and their binding to sn-glycerol-3-
phosphate, and the addition or modification of a polar head group. Usual lipids which are used in membranes comprise
phospholipids, glycolipids, sphingolipids and phosphoglycerides. Fatty acid synthesis starts with the conversion of acetyl-
CoA into malonyl-CoA by acetyl-CoA carboxylase or into acetyl-ACP by acetyl transacylase. After condensation reaction,
these two product molecules together form acetoacetyl-ACP, which is converted via a series of condensation, reduction
and dehydratization reactions so that a saturated fatty acid molecule with the desired chain length is obtained. The
production of the unsaturated fatty acids from these molecules is catalyzed by specific desaturases, either aerobically
by means of molecular oxygen or anaerobically (regarding the fatty acid synthesis in microorganisms, see F.C. Neidhardt
et al. (1996) E. coli and Salmonella. ASM Press: Washington, D.C., pp. 612-636 and references cited therein; Lengeler
et al. (Ed.) (1999) Biology of Procaryotes. Thieme: Stuttgart, New York, and the references therein, and Magnuson, K.,
et al. (1993) Microbiological Reviews 57:522-542 and the references therein). To undergo the further elongation steps,
the resulting phospholipid-bound fatty acids must be returned to the fatty acid CoA ester pool. This is made possible by
acyl-CoA:lysophospholipid acyltransferases. Moreover, these enzymes are capable of transferring the elongated fatty
acids from the CoA esters back to the phospholipids. If appropriate, this reaction sequence can be followed repeatedly.
[0150] Examples of precursors for the biosynthesis of sciadonic acid and juniperonic acid are linoleic acid and linolenic
acid. The C18-carbon fatty acids must be elongated to C20 in order to obtain the required fatty acids and this can be
achieved with a ∆9-elongase. With the aid of the A5-desaturases of the present invention, sciadonic acid and juniperonic
acid can be produced and subsequently employed in various applications regarding foodstuffs, feedstuffs, cosmetics or
pharmaceuticals.
[0151] The synthesized ∆5-unsaturated fatty acids are obtained in the process according to the invention in the form
of the free fatty acid or in the form of their esters, for example in the form of their glycerides.
[0152] The term "glyceride" is understood as meaning glycerol esterified with one, two or three carboxyl radicals
(mono-, di- or triglyceride). "Glyceride" is also understood as meaning a mixture of various glycerides. The glyceride or
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glyceride mixture may comprise further additions, for example free fatty acids, antioxidants, proteins, carbohydrates,
vitamins and/or other substances.
[0153] For the purposes of the invention, a "glyceride" is furthermore understood as meaning glycerol derivatives. In
addition to the above-described fatty acid glycerides, these also include glycerophospholipids and glyceroglycolipids.
Preferred examples which may be mentioned in this context are the glycerophospholipids such as lecithin (phosphati-
dylcholine), cardiolipin, phosphatidylglycerol, phosphatidylserine and alkylacylglycerophospholipids.
[0154] Furthermore, fatty acids must subsequently be translocated to various modification sites and incorporated into
the triacylglycerol storage lipid. A further important step in lipid synthesis is the transfer of fatty acids to the polar head
groups, for example by glycerol fatty acid acyltransferase (see Frentzen, 1998, Lipid, 100(4-5):161-166). Publications
on plant fatty acid biosynthesis and on the desaturation, the lipid metabolism and the membrane transport of lipidic
compounds, on beta-oxidation, fatty acid modification and cofactors, triacylglycerol storage and triacylglycerol assembly,
including the references therein, see the following papers: Kinney, 1997, Genetic Engeneering, Ed.: JK Setlow, 19:
149-166; Ohlrogge and Browse, 1995, Plant Cell 7:957-970; Shanklin and Cahoon, 1998, Annu. Rev. Plant Physiol.
Plant Mol. Biol. 49:611-641; Voelker, 1996, Genetic Engeneering, Ed.: JK Setlow, 18:111-13; Gerhardt, 1992, Prog.
Lipid R. 31:397-417; Gühnemann-Schäfer & Kindl, 1995, Biochim. Biophys Acta 1256:181-186; Kunau et al., 1995,
Prog. Lipid Res. 34:267-342; Stymne et al., 1993, in: Biochemistry and Molecular Biology of Membrane and Storage
Lipids of Plants, Ed.: Murata and Somerville, Rockville, American Society of Plant Physiologists, 150-158, Murphy &
Ross 1998, Plant Journal. 13(1):1-16.
[0155] Phospholipids for the purposes of the invention are understood as meaning phosphatidylcholine, phosphati-
dylethanolamine, phosphatidylserine, phosphatidylglycerol and/or phosphatidylinositol, advantageously phosphatidyl-
choline. The terms production or productivity are known in the art and comprise the concentration of the fermentation
product (compounds of the formula I) which is formed within a specific period of time and in a specific fermentation
volume (for example kg of product per hour per liter). It also comprises the productivity within a plant cell or a plant, that
is to say the content of the desired fatty acids produced in the process relative to the content of all fatty acids in this cell
or plant. The term production efficiency comprises the time required for obtaining a specific production quantity (for
example the time required by the cell to establish a certain throughput rate of a fine chemical). The term yield or product/
carbon yield is known in the art and comprises the efficiency of the conversion of the carbon source into the product
(i.e. the fine chemical). This is usually expressed for example as kg of product per kg of carbon source. By increasing
the yield or production of the compound, the amount of the molecules obtained of this compound, or of the suitable
molecules of this compound obtained in a specific culture quantity over a specified period of time is increased. The terms
biosynthesis or biosynthetic pathway are known in the art and comprise the synthesis of a compound, preferably an
organic compound, by a cell from intermediates, for example in a multi-step and strongly regulated process. The terms
catabolism or catabolic pathway are known in the art and comprise the cleavage of a compound, preferably of an organic
compound, by a cell to give catabolites (in more general terms, smaller or less complex molecules), for example in a
multi-step and strongly regulated process. The term metabolism is known in the art and comprises the totality of the
biochemical reactions which take place in an organism. The metabolism of a certain compound (for example the me-
tabolism of a fatty acid) thus comprises the totality of the biosynthetic pathways, modification pathways and catabolic
pathways of this compound in the cell which relate to this compound.
[0156] Owing to their homology to the ∆5-desaturase, nucleic acids disclosed here, nucleic acid molecules which are
advantageous for the process according to the invention can be isolated following standard hybridization techniques
under stringent hybridization conditions, using the sequences or part thereof as hybridization probe. In this context it is
possible, for example, to use isolated nucleic acid molecules which are least 15 nucleotides in length and which hybridize
under stringent conditions with the nucleic acid molecules which comprise a nucleotide sequence of
[0157] The invention will now be described in greater detail with reference to the following Examples and to the
drawings in which:
Figure 1 is a comparison of the deduced amino acid sequences of A.leveillei and C.palustris desaturases AL10,
AL21 and Cal2 with related sequences.
Figure 2 is a GC-MS analysis of fatty acid methyl esters derived from leaf tissue of wildtype Arabidopsis (A) or
transgenic lines, expressing A. leveillei acyl-CoA desaturase AL21 (B). The presence of additional peaks is indicated
with arrows. The figure shows that AL21 inserts ∆5-double bonds into a range of substrates
Figure 3 shows mass spectral identification of ∆5-fatty acids from transgenic Arabidopsis expressing A.leveillei acyl-
Coa desaturase AL21: a) 18:1∆5, b) authentic compound; c) 16:1∆5; d) 18:3∆5,9,12; e). authentic fatty acid derivative
from a Pinus sp. Diagnostic ions are starred.
Figure 4 is a comparison of Acyl-CoA profiles of transgenic Arabidopsis expressing A.leveillei acyl-CoA desaturase
AL21. Acyl-CoA pools of Arabidopsis leaves from wild-type plants (A) and AL21 transgenic plants (B) were analysed
by HPLC. The presence of additional peaks is indicated with stars. The internal standard is17:0. The figure shows
that desaturation products (*) are present in the acyl-CoA pool.
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Figure 5 is a series of GC profiles showing the expression of A.leveillei acyl-CoA desaturases in transgenic Arabi-
dopsis. Total fatty acid methyl esters derived from leaf tissue of wildtype Arabidopsis (a), ∆9 elongase line CA1-9
(b), double-transgenics CA1-9+ AL21 (C) or CA1-9 + AL10. C20 elongated products are marked with a star, ∆ 5-
unsaturated fatty acids are indicated with solid arrows. The figure demonstrates that co-expression with ∆9 elongase
reveals the function of A10 ∆5-desaturase.
Figure 6 shows MS identification of 20:35,11,14 and 20:45,11,14,17 from transgenic Arabidopsis plants co-express-
ing the A.leveillei acyl-CoA desaturases AI10 and AI21 and IgASE1.
Figure 7 is a series of Acyl-CoA profiles of transgenic Arabidopsis co-expressing A.leveillei acyl-CoA desaturase
AL21 and IgASE1. Acyl-CoA pools of Arabidopsis leaves from ∆9 elongase line CA1-9 (A) and double-transgenic
CA1-9 + AL10 plants (B) were analysed by HPLC. The presence of additional peaks is indicated with stars. The
internal standard is17:0. ∆ 5-unsaturated fatty acids are indicated with solid arrows. The figure shows that C20
NMIFAs are present in the acyl-CoA pool of transgenic plants co-expressing AI10 and IgELO9.
Figure 8 Functional expression in yeast in the presence of exogenous substrates.
FIGURE 9a is a GC profiles of an A. thaliana leaf fatty acid methyl esers, extracted from a doule transgenic plant
expressing the A. leveillei ∆5-desaturase AI21 and I. galbana ∆9-elongase.
FIGURE 9b is a GC profiles of an A. thaliana leaf fatty acid methyl esers, extracted from a single transgenic plant
expressing the I. galbana ∆9-elongase.
FIGURE 10 shows an acyl CoA profile of an Arabidopsis single transgenic plant expressing IgASE1. The accumu-
lation of 20:2 and 20:3 is observed, representing the elongation of LA and ALA, and the failure of these elongation
products to accumulate in glycerolipids.
FIGURE 11 shows an acyl CoA profile of a double transgenic plant expressing IgASE1 and A. leveillei ∆5-desaturase
AI21.
[0158] For reasons of clarity:
AI10 shall be identical to AlCoa10
AI21 shall be identical to AlCoa21
Cal2 shall be identical to CalCoa2
Example 1
Materials and Methods.
Plant material.
[0159] Seeds were obtained from Chiltern Seeds, Cumbria, UK.
Nucleic acid manipulation.
[0160] Total RNA was isolated from developing seeds of Anemone leveillei and Caltha palustris using the RNAeasy
kit (Qiagen).
PCR-based cloning.
[0161] Two degenerate primers were designed to conserved amino acid sequences corresponding to the histidine
boxes and identified in previously characterized acyl-CoA desaturases: forward primer Des2F:
5’- TGGGTI(A/T)(G/C)IA(C/T)ICA(T/C)(C/A)GITA(T/C)CA(T/C)-
[0162] (SEQ ID NO 7) designed to encode histidine box II (WVSTHRYHHQF) and reverse primer DesR:
5’- GC(A/G)TG(A/G)TG(A/G)TT(A/G)TT(A/G)TGCCAICC(T/C)TCICC,
[0163] (SEQ ID NO: 8) designed to encode the complement of histidine box III (GEGWHNNHHA), where I substitutes
inosine.
[0164] These primers were used for PCR amplification with cDNAs transcribed from total RNA isolated from developing
seeds of Anemone leveillei and Caltha palustris using previously described protocol (Sayanova et al, PNAS, 1997; 94:
4211-4216). The PCR fragments of the expected length (420 bp) were cloned into TOPO TA vector (Invitrogen) and
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sequenced. Data bank searches and alignments with these new sequences showed similarities to acyl-CoA desaturas-
eses for two different fragments from A .leveillei and one from C. palustris. The derived sequence data were used to
design primers for the amplification of 5’- and 3’ ends of putative desaturases using a SMART RACE cDNA Amplification
kit (BD-Clontech).
[0165] The resulting 5’- and 3’- RACE products were used to amplify full-length copies of the two putative desaturases
from cDNAs of Anemone leveillei designated AI10 (SEQ ID NO: 5) and AI21 (SEQ ID NO: 3) respectively and one
putative desaturases from cDNAs of Caltha palustris designated Cal2 (SEQ ID NO: 1). Gene -specific primers were
designed to the 5’- and 3’ -ends of the coding regions of the corresponding desaturase sequences with restriction sites
to facilitate cloning into plant vectors. The following pairs of forward/reverse (F/R) primers were used (restriction sites
are indicated in bold).
[0166] Cal2:
SalF: GGTCGACATGGCTCTAATTGCAACAACCCCCAAA (SEQ ID NO: 9);
ClaF: GATCGATATGGCTCTAATTGCAACAACCCCCAAA (SEQ ID NO: 10);
SacR: GAGCTCTTACTCGCTGAAACACATCC (SEQ ID NO: 11);
ClaR:GATCGATTTACTCGCTGAAACACATCC (SEQ ID NO: 12);
[0167] Al10
XbaF: GGTCTAGAATGGATCTCACATCAATGG (SEQ ID NO: 13);
NotF: GGCGGCCGCATGGATCTCACATCAATGG (SEQ ID NO: 14);
ClaF: GATCGATATGGATCTCACATCAATGG (SEQ ID NO: 15);
SalR: GGTCGACTCAATTTTTGAAAGACATCTTACGCTTG (SEQ ID NO: 16);
NotR: GGCGGCCGCTCAATTTTTGAAAGACATCTTACGCTTG (SEQ ID NO: 17).
[0168] Al21
SmaF:GGCCCGGGATGGAACTCCCAGCGAT (SEQ ID NO: 18);
NotF: GGCGGCCGCATGGAACTCCCAGCGAT (SEQ ID NO: 19);
ClaF: GATCGATATGGAACTCCCAGCGAT (SEQ ID NO: 20);
SalR: GGTCGACTTACTTGTCGTTCACACAGAAC (SEQ ID NO: 21);
NotR: GGCGGCCGCTTACTTGTCGTTCACACAGAAC (SEQ ID NO: 22);
CIaR:GATCGATTTACTTGTCGTTCACACAGAAC (SEQ ID NO: 23).
Functional expression in yeast.
[0169] All coding regions corresponding to A. leveillei desaturases were inserted as Cla1/Cla1 fragments into the
yeast pYES2.1 TOPO TA expression vector. Coding region corresponding to Isochrysis galbana C18-∆9-elongase,
ASE1, was inserted as a Kpn1-BamH1 fragment into the pYES3 expression vector. Forward primers were designed to
contain a G at position -3 and +4 to improve translation initiation in eukaryotic cells. ORFs encoding putative desaturation
activities were introduced in S.cerevisiae strain W303-1A by a lithium acetate method as previously described (Sayanova
et al., 2003, FEBS Letters, 542,100-104). Cultures were grown at 22oC in the presence of 2% (v/v) raffinose and
expression of the transgenes was induced by the addition of galactose to 2% (w/v) in the presence of 0.5 mM of the
corresponding fatty acid and 1% (w/v) tergitol -Nonidet P-40 (Sigma) as described. Yeast transformants containing
pYES2-derived constructs were grown on synthetic minimal medium minus uracil; pYES3-derived constructs were grown
on minimal medium minus tryptophan. Co-transformed yeast was grown on minimal medium minus uracil and tryptophan.
Plant transformation constructs.
[0170] All coding regions used were placed in CaMV 35S promoter- nos terminator expression cassettes. The coding
regions of Al10 and Al21 were inserted as XbaI/SaII-and Smal/Sall fragments respectively into the binary vector
pBIN19-35S, kindly provided by Dr. P.Buchner.
[0171] The coding region of CalCoa2 was inserted as a Sall/Sacl fragment into the vector pJD330 and excised with
BamHI/XbaI for insertion into pBin19. For seed specific expression both coding regions of AlCoa10 and Alcoa21 were
inserted as NotI fragments into expression vector pKMS2 (donated by Dr. E. Cahoon).
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Plant transformation.
[0172] Binary plasmids were transferred to Agrobacterium tumifaciens strain GV3101 by electroporation and kanamy-
cin-resistant colonies were selected. Wild type Arabidopsis thaliana ecotype Columbia plants and transgenic Arabidopsis
plants harbouring the ∆9-specific elongase from Isochrysis galbana, IgASE1 (Qi et al. 2004 Nature Biotechnology 22:
739-745), were transformed by the floral dipping method (Clough and Bent, 1998, Plant Journal 16: 735-743). Kanamycin-
resistant plants for each construct were selected and transplanted to soil and analysed.
Fatty acid analysis.
[0173] Fatty acids were extracted and methylated as described (Sayanova et al., 2003, FEBS Letters, 542,100-104).
Methyl ester derivatives of total fatty acids extracted from leaves were analysed by GC and GC-MS. For the determination
of the double bond positions fatty acids methyl esters were converted to the 4,4-dimethyloxazoline (DMOX) derivatives
(Fay and Richli, 1991, Journal of Chromatography 541: 89-98). The derivatives were submitted to gas chromatography-
mass spectrometry (GC-MS), with a Hewlett Packard 5890 Series II plus gas chromatograph attached to an HP model
5989 MS engine. The latter was used in the electron impact mode at 70 eV with a source temperature of 250oC. The
GC was fitted on-column injection, and was equipped with a capillary column of fused silica coated with Supelcowax
10TM (0.25 mm x 25 m, 0.25 Pm film; Supelco UK, Poole, UK). After holding the temperature at 80oC for 3 min, the
column was temperature -programmed at 20oC/min to 180oC, then at 2oC/min to 280oC, where it was held for 15 min.
Helium was the carrier gas at a constant flow-rate of 1mL/min.
Acyl-CoA analysis.
[0174] For acyl-CoA analysis the method developed by Larson and Graham for plant tissues was used (Larson and
Graham, 2001, Plant Journal 25: 115-125).
Results
Isolation of putative acyl-CoA desaturases from Ranunculaceae species.
[0175] The seed oils of A.leveillei and C.palustris contain significant amounts of sciadonic acid. Therefore, the devel-
oping seed of these two species were used for RNA extraction and further analysis.
[0176] A PCR based approach was used to identify cDNAs for ∆5cis-desaturase. Degenerate primers (SEQ ID NO:
7 and SEQ ID NO: 8) designed to the histidine boxes identified in previously isolated putative acyl-CoA desaturases
from rose and Arabidopsis were used.
[0177] The resulting 420 bp fragments were sequenced yielding two different types of sequences from A. leveillei and
one type of sequence from C. palustris. All of them showed a high level of identity to putative acyl-CoA desaturase-like
polypeptides from higher plants such as Arabidopsis; they also show some similarity to the partial sequence described
by Cahoon et al (2000, Plant Physiology 124: 243-251) for the Limnanthes ∆5-desaturase. These partial sequences
were used to design 5’ and 3’-RACE primers to amplify both ends of three putative acyl- CoA desaturases. Total RNA
isolated from A.leveillei and C.palustris seeds was used as a template in all the RACE reactions. The sequence data
acquired from 3’ and 5 RACE were used to design primers to the 5’ and 3’- ends of the coding regions of each of the
three genes (SEQ ID NOS: 9-23). The primers also contained restriction sites to facilitate the cloning of these genes
into the binary vectors for plant expression. Full-length copies of these cDNA clones were amplified directly from the
corresponding cDNAs. These primers successfully amplified two full-sized cDNA clones from A. leveillei, designated
Al10 (SEQ ID NO: 3) and Al21 (SEQ ID NO: 5) and two cDNA clones from C. palustris, designated Cal1 and Cal2 (SEQ
ID NO: 1). The cDNAs encode polypeptides of 378 (Cal1), 376 (Cal2, SEQ ID NO: 2), 312 (Al10, SEQ ID NO: 4) and
321 (Al21, SEQ ID NO: 6) amino acids. Polypeptides corresponding to cDNA clones Cal1 and Cal2 were almost identical
except Cal1 contained an insertion of two amino acids at the position 60 (Leu Asp) (sequence not included). For further
analysis we used cDNA clone Cal2. All four polypeptides were found to share up to 25% amino acid sequence identity
with ∆9 -acyl CoA desaturases from rat and human, but were most related to acyl-CoA desaturase like polypeptides
from L. douglasii, rose and Arabidopsis (Fig. 1).
[0178] Expression of A.leveillei and C.palustris putative Acyl-CoA Desaturases in A.thaliana. The coding regions for
the three polypeptides, Cal2, Al10 and Al21, were introduced into plant expression vectors under the control of the CAMV
35S promoter and resulting constructs were used to transform A. thaliana plants. GC profiles of total fatty acids extracted
from leaves of wild-type and transgenic plants transformed with Al10 and AL21 constructs show the presence of several
mono- and polyunsaturated fatty acids that were not detected in wild type Arabidopsis (Fig. 2). These novel fatty acids
were identified by GC-MS analysis of a DMOX derivatives of their methyl esters as previously described (Fay and Richli,
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1991, Journal of Chromatography 541: 89-98). This confirmed their identities as ∆5 isomers of 16:1, 18:1, 18:3 and 18:
4 fatty acids (Fig. 3). A double bond in position 5 in a DMOX derivative is usually characterized by a fingerprint of ions
at m/z = 153, 166, and 180. Thus, the double bond position of 18:1 was confirmed from the spectrum shown in Fig 3a
which can be compared with that of the authentic compound (Fig 3b). 16:1∆5 was essentially the same in the key region
of the spectrum, differing only in the area of molecular ion (Fig. 3c). Fatty acid 18:3∆5,9,12 was identified from comparisons
of authentic spectra shown in Fig. 3d,e. The abundant ion at m/z= 180 is highly characteristic of a 5,9-double bond
system. MS analysis confirmed the presence of double bonds in positions 9 and 12 (located by gaps of 12 amu between
m/z = 194 and 206 and 234 and 246, respectively) and in the position 5, indicated by the especially abundant key
diagnostic ion at m/z = 180 representing cleavage at the centre of the bis-methylene-interrupted double bond system.
[0179] The most abundant of these fatty acids was 16:1 ∆5 which accounted for 1.8% (w/w) of the total fatty acids.
The ∆5 isomers of 18:1, 18:3 and 18:4 each participated to less than 1% of the total fatty acids in the transgenic
Arabidopsis. However, no ∆5 - unsaturated fatty acids were found in transgenic Arabidopsis plants expressing Al10.
Plants expressing Cal2 produced very small amounts of 16:0 (<1%).
[0180] Analysis of the acyl-CoA pools of leaf tissues of Arabidopsis transformed with both constructs, Al10 and Al21
was carried out (Fig. 4). This revealed the presence of the ∆5 -desaturated fatty acids corresponding to 16:1, 18:1 18:
3 and 18:4 in transgenic plants, expressing Al21. Especially high were levels of 16:1∆5 in transgenic plants expressing
AL21. In the case of the acyl-CoA profiles for the leaves of the plants expressing AL10, the presence of the ∆5 -desaturated
fatty acids was not detected.
Co-expression of A. leveillei and C. palustris Acyl-CoA Desaturases in IgASE1 transgenic A. thaliana.
[0181] Since the synthesis of SA requires the presence of 20:2 n-6 as a substrate, we used Arabidopsis lines engineered
to accumulate this fatty acid. Kanamycin resistance was used as a selectable marker in transformation of Liberty herbicide
resistant IgASE1-line (which expresses the C18-∆9 -elongase from Isochrysis galbana (SEQ ID NO: 25) and therefore
synthesises 20:2, n-6 and 20:3, n-3) with constructs containing A. leveillei and C. palustris acyl-CoA desaturases coding
regions under the control of the CaMV 35S promoter. 40 independent double transgenic lines (i.e. BASTA and Kan
resistant) for each of the constructs, AL10 and AI21, were obtained by A. tumefaciens - mediated transformation. Two
additional peaks appeared in the GC profiles of the leaf fatty acids of the double transgenic lines harbouring both A.
leveillei putative acyl-CoA desaturase activities, AI10 and AI21, compared to its single transgenic parent (Fig. 5). These
were identified by GC-MS analysis as sciadonic acid (C20:3 ∆5cis,11,14) and juniperonic acid (JA, C20:4 ∆5cis,11,14,17),
respectively, on the basis of the retention times of known standards and m/z (Fig. 6). GC- MS analysis of the leaf fatty
acids of double transgenic Arabidopsis plants expressing AL21 also confirmed the presence of additional peak corre-
sponding to 16:1 ∆5.
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Table Ia. Total fatty acid composition of leaves from transgenic A. thaliana plants
Fatty 
acids
16:0 16:15 16:19 16:2 16:3 18:0 18:1 18:2 18:3 20:2 11,14 20:
3 5,11,14
20:
311,14,17
20:
4 5,11,14,17
Elo9 14.90.8 - 3.80.3 2.00.1 19.40.1 0.90.1 1.60.4 8.01.0 472.5 3.31.5 - 3.82.0 -
AL21+ 
Elo9
11.10.3 0.60.1 2.70.4 2.50.2 22.90.8 0.50.2 1.70.3 5.21.5 421.1 0.740.3 0.50.1 2.91.0 1.30.1
AL10+ 
Elo9
13.40.5 - 3.30.2 3.40.1 18.81.5 0.60.4 2.20.2 5.30.9 431.1 1.90.4 1.50.2 3.11.1 1.40.3
The values are mol% SD (n=4).
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[0182] SA and JA accounted for 0.5% and 1.3 % of total fatty acids in plants expressing AL21 (Table la) and represented
a conversion of 40% and 31% of their respective substrates. In plants expressing AL10 SA and JA accounted for 1.5%
and 1.1% respectively and represented a conversion of 44% and 31% of their respective substrates. Single transgenic
plants expressing ∆9 -elongase activity accumulated C20:2 and C20:3 fatty acids to 3.3 % and 3.8 % of total fatty acids.
[0183] SA and JA accounted for 1% and 0.8% of total fatty acids (Table Ib) and represented a conversion of 53% and
44% of their respective substrates. Single transgenic plants expressing ∆9 -elongase activity accumulated C20:2 and
C20:3 fatty acids to 4.5 % and 3.0 % of total fatty acids, similar to those observed previously.
[0184] Analysis of the acyl-CoA pool of the Isochrysis galbana ∆9 (IsoD9) elongase-containing transgenic plants
(IgASE1) revealed the accumulation of high levels of acyl-CoAs representing the elongation products of linoleic acid
(LA) and linolenic acid (ALA) (i.e. 20:2 n-6 and 20:3 n-3). These latter products represent potential substrates for the
Anemone desaturase, especially if the enzyme utilises acyl-CoA substrates. it should also be noted that the accumulation
of 20:2-CoA and 20:3-CoA in the IgASE1 lines is likely to represent poor transfer of the these esters from the CoA pool
into glycerolipids, and may imply they are poor substrates for endogenous Arabidopsis acyltransferases. When the acyl-
CoA pool for lines co-expressing the IgASE1 elongase and Anemone desaturase were examined, considerable conver-
sion of 20:2 and 20:3 to SA and JA was observed (see Fig 7 for details). As has previously been observed with analysis
of PUFA acyl-CoAs, separation of regioisomers is potentially difficult. However, SA accumulates as an overlapping peak
with the 20:3 n-3 peak (i.e. the elongation product of ALA). In the case of JA, this elutes close to 18:2, and we reason
that the JA peak is likely to be the larger of the two (based on retention time and no alteration to endogenous 18:2 fatty
acid levels in these lines).
Functional characterization of A.leveillei AL 10 and AL21 desaturases in yeast.
[0185] The two full-length cDNAs corresponding to the two A.leveillei AI10 and AI21 ORFs were cloned in pYES2
vector and expressed in yeast under the control of galactose inducible GAL1 promoter in the presence of either 20:2 or
20:3 exogenous substrates. GC analysis of fatty acid methyl esters (FAMEs) revealed that transformed yeast cells were
able to produce additional fatty acids that were not detected in controls. These fatty acids were identified by GC-MS-
analysis as ∆5cis-20:3 -and 20:4 NMIP-fatty acids. Each new putative ∆5-unsaturated fatty acid accounted for <1% of
the total fatty acids of transgenic yeast (Fig. 8). To obtain higher levels of ∆5-unsaturated fatty acids in transgenic yeast
we co-expressed both A. leveilei ∆5 desaturases with the C18-09 PUFA-specific elongase IgASE1 from Isochrysis
galbana in the presence of two different substrates, 18:2, n-6 or 18:3, n-3. The results indicated that combination of
elongation and desaturation activities has not generated better amounts of Sciadonic and Juniperonic acids in yeast
(results not shown).
[0186] We therefore conclude that we have functionally indentified the ∆5-desaturase responsible for the NMI-desat-
uration and the synthesis of sciadonic and juniperonic acid. Moreover, we show that this enzyme is an acyl-CoA desat-
urase, and therefore represents the first cloned and characterised example of such an activity from higher plants. It is
very likely that it would be possible to increase the accumulation of SA and JA in transgenic plants by optimising their
exchange out of the acyl-CoA pool, by the co-expression of a suitable acyltransferases.
Table Ib. Total fatty acid composition of leaves from single and double transgenic A. thaliana plant
Fatty acids 16:0 16:1 16:2 16:3 18:0 18:1 18:2 18:3 20:2 SA 20:3 JA
Al1028 14.0 4.0 0.7 4 13.8 1.6 3.6 12.6 5 45. 7 0.8 0.92 1.0 0.8
IgASE1 11.0 2.8 0. 13.5. 0 0.8 3.5 8.2 30. 5 5.5 - 4.4 4.4 -
Acyl-CoA profiling of double- and single- transgenic A. thaliana plants.
Recent studies of PUFAs biosynthesis in transgenic plants suggest that the microsomal elongase uses acyl CoA
as a substrate.
Table II. Fatty acid profile of the Acyl-CoA pool of a single and double transgenic A.thaliana. plants.
FA 16:0 18:0/22:3 18:1 18:2 18:2/JA 18:3 20:0 20:1 20:2 20:3 20:3/SA
IgASE1 16.3 1.8 1.1 2.4 - 6.0 2.3 1.0 23.6 17.3 -
Al1028 14.2 3.4 1.7 - 12.4 4.4 2.3 1.3 27.0 27.0 - 32.1
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Example 2
Generation of transgenic plants
a) Generation of transgenic oilseed rape plants (modified method of Moloney et a/., 1992, Plant Cell Reports, 8:238-242)
[0187] Binary vectors in Agrobacterium tumefaciens C58C1:pGV2260 or Escherichia coli (Deblaere et al, 1984, Nucl.
Acids. Res. 13, 4777-4788) can be used for generating transgenic oilseed rape plants. To transform oilseed rape plants
(Var. Drakkar, NPZ Nordeutsche Pflanzenzucht, Hohenlieth, Germany), a 1:50 dilution of an overnight culture of a
positively transformed agrobacterial colony in Murashige-Skoog medium (Murashige and Skoog 1962 Physiol. Plant.
15, 473) supplemented with 3% sucrose (3MS medium) is used. Petiols or hypocotyls of freshly germinated sterile
oilseed rape plants (in each case approx. 1 cm2) are incubated with a 1:50 agrobacterial dilution for 5-10 minutes in a
Petri dish. This is followed by 3 days of coincubation in the dark at 25°C on 3MS medium supplemented with 0.8% Bacto
agar. The cultures are then grown for 3 days at 16 hours light/8 hours dark and the cultivation is continued in a weekly
rhythm on MS medium supplemented with 500 mg/l Claforan (cefotaxim sodium), 50 mg/l kanamycin, 20 PM benzylami-
nopurine (BAP), now supplemented with 1.6 g/I of glucose. Growing shoots are transferred to MS medium supplemented
with 2% sucrose, 250 mg/l Claforan and 0.8% Bacto agar. If no roots develop after three weeks, 2- indolebutyric acid
was added to the medium as growth hormone for rooting. Regenerated shoots were obtained on 2MS medium supple-
mented with kanamycin and Claforan; after rooting, they were transferred to compost and, after growing on for two weeks
in a controlled-environment cabinet or in the greenhouse, allowed to flower, and mature seeds were harvested and
analyzed by lipid analysis for elongase expression, such as ∆5-elongase or ∆6-elongase activity or ω3-desaturase
activity. In this manner, lines with elevated contents of polyunsaturated C20- and C22-fatty acids can be identified.
b) Generation of transgenic linseed plants
[0188] Transgenic linseed plants can be generated for example by the method of Bell et al., 1999, In Vitro Cell. Dev.
Biol.-Plant. 35(6):456-465 by means of particle bombardment. In general, linseed was transformed by an agrobacteria-
mediated transformation, for example by the method of Mlynarova et al. (1994), Plant Cell Report 13: 282-285.
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Claims
1. A process for the production of a compound of formula (I):
in an organism, the process comprising introducing into an organism which comprises a lipid of general formula (III):
at least one nucleic acid sequence comprising :
a) SEQ ID NO: 3;
b) a nucleic acid sequence which hybridizes under stringent conditions with a nucleic acid sequence of SEQ
ID NO: 3.
c) a nucleic acid sequence which encodes a polypeptide of SEQ ID NO: 4; or
d) a derivative of a nucleic acid sequence of SEQ ID NO: 3 which encodes a polypeptide with at least 40%
identity at the amino acid level with SEQ ID NO: 4, wherein said polypeptide has ∆5-desaturase activity;
and expressing said nucleic acid sequence;
wherein, in general formulae (I) and (III):
Y = a C10-C18 hydrocarbon chain containing up to four carbon-carbon double bonds;
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphati-
dylglycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol, sphingo base or a rad-
ical of the formula II:
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in which
R2 = hydrogen, lysophosphatidyl choline, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysodi-
phosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturated
C2-C24-alkylcarbonyl,
R3 = hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl, or R2 and R3 independently of one another
are a radical of the formula la:
in which
n = 2, 3, 4, 5, 6, 7 or 9, m = 2, 3, 4, 5 or 6 and p = 0 or 3;
and wherein an oxygen in the R1 radical may be replaced by sulphur such that R1 is bonded to the
remainder of the molecule via a thioester linkage.
2. A process as claimed in claim 1 wherein, in the compound of formula (I), the -CH=CH- double bond is in the cis
orientation.
3. A process as claimed in claim 1 or claim 2 wherein, in the moiety Y, the carbon-carbon double bonds are in the cis
orientation.
4. A process as claimed in claim 1 or claim 2, wherein in the compound of general formula (I) Y is:
-(CH2)4-CH=CH-CH2-CH=CH-(CH2)4-CH3, such that the compound of general formula (I) is sciadonic acid or
a derivative thereof;
-(CH2)4-CH=CH-CH2-CH=CH-CH2-CH=CH- CH2-CH3, such that the compound of general formula (I) is juni-
peronic acid or a derivative thereof.
5. A process for the production of a compound of general formula (I) as defined in claim 1 and in which Y is:
-(CH2)4-CH=CH-CH2-CH=CH-(CH2)4-CH3;
or
-(CH2)4-CH=CH-CH2-CH=CH-CH2-CH=CH- CH2-CH3;
in an organism which comprises linoleic (C18:2 n-6) or linolenic (C18:3 n-3) acid, the process comprising introducing
into the organism:
at least one nucleic acid sequence comprising :
a) SEO ID NO: 3;
b) a nucleic acid sequence which hybridizes under stringent conditions with a nucleic acid sequence of
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SEQ ID NO: 3.
c) a nucleic acid sequence which encodes a polypeptide of SEQ ID NO: 4; or
d) a derivative of a nucleic acid sequence of SEQ ID NO: 3 which encodes a polypeptide with at least 40%
identity at the amino acid level with SEQ ID NO: 4 wherein said polypeptide has ∆5-desaturase activity; and
at least one nucleic acid sequence encoding a polypeptide having ∆9 elongase activity;
and expressing said nucleic acid sequences;
6. A process as claimed in claim 5, wherein the nucleic acid sequence encoding a polypeptide having ∆9 elongase
activity comprises a sequence encoding the C18-∆9 elongase from Isochrysis galbana (SEQ ID NO: 25) or Acan-
thamoeba castellanii (SEO ID NO: 24)
7. The process according to any of claims 1 to 6, wherein the substituents R2 or R3 independently of one another are
saturated or unsaturated C18-C22-alkylcarbonyl.
8. The process according to any of claims 1 to 7, wherein the substituents R2 or R3 independently of one another are
unsaturated C18-, C20- or C22-alkylcarbonyl with at least two double bonds.
9. The process according to any of claims 1 to 8, wherein the transgenic organism is a transgenic microorganism or
a transgenic plant.
10. The process according to any of claims 1 to 9, wherein the transgenic organism is an oil-producing plant, a vegetable
plant or an ornamental.
11. The process according to any of claims 1 to 10, wherein the transgenic organism is a transgenic plant selected from
the group of the plant families: Adelotheciaceae, Anacardiaceae, Asteraceae, Apiaceae, Betulaceae, Boraginaceae,
Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae, Chenopodiaceae, Crypthecodiniaceae,
Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae, Jug-
landaceae, Lauraceae, Leguminosae, Linaceae or Prasinophyceae.
12. The process according to any of claims 1 to 11, wherein the compounds of the formula I are isolated from the
organism in the form of their oils, lipids or free fatty acids.
13. The process according to any of claims 1 to 12, wherein the compounds of the formula I are isolated in a concentration
of at least 1% by weight based on the total lipid content of the transgenic organism.
14. The oil, lipid or fatty acid, or a fraction thereof, produced by the process according to any of claims 1 to 13.
15. An oil, lipid or fatty acid composition which comprises an oil, lipid or fatty acid produced by a process as claimed in
any one of claims 1 to 14 and which is derived from transgenic plants.
16. A process for the production of oils, lipids or fatty acid compositions by mixing oils, lipids or fatty acids according to
claim 15 or oil, lipid or fatty acid compositions according to claim 15 with animal oils, lipids or fats.
17. An isolated nucleic acid sequence which encodes a polypeptide with ∆5-desaturase activity and which is selected
from the group consisting of SEQ ID NO: 3.
18. A derivative of a nucleic acid sequence of SEQ ID NO:3 which encodes a polypeptide with at least 40% identity at
the amino acid level with SEQ ID NO: 4, wherein said polypeptide has ∆5-desaturase activity.
19. An amino acid sequence which is encoded by a nucleic acid sequence according to claim 17 or claim 18.
20. A nucleic acid construct comprising a nucleic acid sequence according to claim 17 or claim 18, operably linked with
one or more regulatory sequences.
21. A gene construct according to claim 20, further comprising a nucleic acid sequence encoding a polypeptide having
∆9-elongase activity.
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22. A gene construct according to claim 21, wherein the nucleic acid sequence encoding a polypeptide having ∆9
elongase activity comprises a sequence encoding the C18-∆9 elongase from Isochrysis galbana (SEQ ID NO:25)
or Acanthamoeba castellanii (SEQ ID No:24).
23. A gene construct according to claim 21 or claim 22, wherein the nucleic acid construct comprises additional biosyn-
thesis genes of the fatty acid or lipid metabolism selected from the group acyl-CoA dehydrogenase(s), acyl-ACP [=
acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s),fatty acid acyltransferase(s), acyl-CoA:lysophosphol-
ipid acyltransferase(s), fatty acid synthase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-
coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenases, lipoxygenases, triacylglycerol lipases,
allenoxide synthases, hydroperoxide lyases or fatty acid elongase(s).
24. The gene construct according to claim 22 or claim 23, wherein the nucleic acid construct comprises additional
biosynthesis genes of the fatty acid or lipid metabolism selected from the group ∆4-desaturase, ∆5-desaturase, ∆6-
desaturase, ∆8-desaturase, ∆9-desaturase, ∆12-desaturase or ∆6-elongase.
25. A vector comprising a nucleic acid according to claim 17 or claim 18 or a gene construct according to any one of
claims 20 to 24.
26. A transgenic nonhuman organism comprising at least one nucleic acid according to claim 17 or claim 18, a gene
construct according to any one of claims 19 to 23 or a vector according to claim 24.
27. The transgenic nonhuman organism according to claim 26, which organism is a microorganism, a nonhuman animal
or a plant.
28. The transgenic nonhuman organism according to claim 26 or claim 27, which organism is a plant.
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